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ABSTRACT 
 
 Animal health is a major concern in today’s livestock industry.  Not only is 
animal illness costly, but it also affects all aspects of the industry from the cow calf 
producer to the feedlot operator.  Bovine respiratory disease (BRD) has large economic 
ramifications to the beef industry.  Bovine respiratory disease has been characterized an 
interaction between environment, stress, and infectious pathogens.  Preventative methods 
such as vaccination have been used to minimize the repercussions that have been 
associated with BRD.  While vaccination has been used as a preventative method, it is 
only effective if an immune response is mounted to the specific antigen present in the 
vaccine. The objectives of the studies were three fold: 1) to identify sources of fixed 
effects that influence maternal antibody levels and maternal antibody decay, 2) to identify 
the environmental and management factors that influence antibody response to BVDV2 
vaccine, and 3) to evaluate effects of BVDV2 antibody response on body composition 
ultrasound, performance, and carcass quality traits.  In these studies, immune response 
was measured by antibody response to bovine viral diarrhea virus type 2 (BVDV2). With 
respect to objectives 1 and 2: calf age nested within birth year season and dam age 
significantly (P<0.05) affected all passively-acquired maternal antibody level and vaccine 
response traits evaluated.  The amount of circulating passively-acquired maternal 
antibodies present at the time of vaccination has a significant (P<0.05) effect on antibody 
response to vaccination for final antibody level and initial, booster, and overall response.  
Calves that were weaned at the initial vaccination had significantly (P<0.05) higher final 
antibody levels and response to vaccination compared to animals weaned at the booster 
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vaccination.  In order to mount an antibody response to vaccination, maternal antibodies 
in circulation need to be below a given threshold.   
With respect to objective 3, increased final antibody level significantly (P<0.05) 
increased yearling weight and subcutaneous fat over the rump. The interaction between 
final antibody level and wean stress treatment had a significant (P<0.05) effect on 
Warner-Bratzler shear force (WBSF) and pH.  While, overall antibody response by wean 
stress interaction had a significant (P<0.05) effect on ADG and pH.  Animals weaned at 
initial vaccination had significantly (P<0.05) higher intramuscular fat and harvest weights 
than animals weaned at the booster vaccination, with no significant (P<0.05) effects from 
final antibody level or overall response.  Animals that were weaned at the initial 
vaccination with high response level had significantly (P<0.05) higher ADG, harvest 
height, and HCW compared to animals with a high response level weaned at the booster 
vaccination.  Increased antibody response did not significantly (P<0.05) decrease 
performance or carcass quality in finished cattle.  Overall increased antibody response to 
vaccination did not jeopardize performance or carcass quality.  Decreased maternal 
antibodies at vaccination and weaning calves at the initial vaccination allowed for greater 
response to vaccination. Additionally, animals weaned at the initial vaccination and had 
high response to the vaccination had increased performance.  Taken together these 
results, provide needed information for producers so that they can maximize the 
effectiveness of vaccination, which should help them to better control BRD. 
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CHAPTER 1. 
GERNERAL INTRODUCTION 
Introduction 
 Resistance to bovine respiratory disease (BRD) incidence is a lowly heritable 
trait.  BRD affects all aspects of the beef industry from the cow/calf producer to feedlot 
operators.  Since BRD is an extremely costly trait to the beef industry, alternative traits 
have been investigated to allow genetic selection for improved resistance to BRD.  One 
alternative trait is response to vaccination.  Vaccination has been used as the primary 
preventative method to reduce BRD prevalence and minimize economic losses attributed 
to BRD.  Vaccination occurs in all production phases and tends to occur during high 
periods of stress that may suppress the immune response to vaccination.  Therefore, 
selection of animals capable of utilizing the vaccination to respond to BRD would be 
very valuable. 
 Animal health has become a focal point of the beef industry due to associated 
costs, regulations, viral evolution and lack of new vaccine development. For these 
reasons, genetic selection of animals for enhanced immune response and increased 
vaccine efficacy is an appealing strategy to reduce BRD.  Additionally, genetic selection 
strategies would allow improved response to vaccination during high stress periods (e.g. 
weaning, feedlot transition) that may otherwise reduce vaccination efficacy.  
 To determine the major factors in developing genetic selection strategies to 
reduce BRD, we had three research objectives. 1) Identify environmental and 
management factors that effect maternal antibody transfer and maternal antibody decay.  
2) Identify environmental and management factors that effect antibody production and 
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response to bovine viral diarrhea virus type 2 vaccinations.  Finally, 3) identify the effects 
of antibody response and timing of wean stress on body composition ultrasound traits, 
performance, and carcass quality in finished market cattle. 
Thesis Organization 
 This thesis is composed of an abstract, a general introduction, literature review, 
two individual papers, a general summary, and an appendix.  Each paper consists of an 
abstract, introduction, materials and methods, and results and discussion.  References 
cited within the literature review, the three papers, and the appendix are located at the end 
of each section, followed by tables and figures.  The papers are written for submission to 
the Journal of Animal Science, and follow the Journal of Animal Science Style and 
Format.  The appendix is written as a Beef Improvement Federation (BIF) meeting 
proceedings and is published in the 2011 BIF Proceedings.   
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CHAPTER 2. 
LITERATURE REVIEW 
Bovine Respiratory Disease 
Bovine respiratory disease (BRD) has both the highest incidence rate of all 
diseases and the largest economic impact on the North American feedlot industry (Duff 
and Galyean, 2007; Holland et al., 2010). Bovine respiratory disease affects all phases of 
production, not just through animal death but also through large production losses.  
Bovine respiratory disease has been characterized as a complex interaction between 
infectious agents, environment, and stress, which creates a multifactorial disease 
(Galyean et al., 1999; Step et al., 2008).  Respiratory diseases have been hard to identify 
and diagnosis, and expensive to treat, additionally studies have shown little opportunity 
for genetic improvement through traditional selection against BRD (Schneider et al., 
2010; Snowder, 2009).  Therefore, improved methods of disease prevention, such as 
management practices or genetic improvement for immune response, could reduce risks 
associated with BRD and benefit all aspects of beef production.   
The USDA surveyed feedlot production systems for estimates of BRD presence in 
the North American feedlot industry.  In a study from 1999, feedlot BRD incidence rates 
across 12 states were reported at 14.4% (USDA-APHIS, 2001).  In addition, a survey in 
2005 reported that 12.8% of feedlot cattle were treated for BRD (Woolums et al., 2005). 
This indicated that little improvement was observed in the reduction of BRD incidence in 
feedlots in six years.  Illness caused by BRD could account for 75% of morbidity and 50 
to 70% of all feedlot mortality (Holland et al., 2010).  BRD has an estimated economic 
impact of $750 million annually on the beef industry, with losses attributed to: treatment 
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costs, increased labor needs, morbidity, mortality, and loss of performance and carcass 
quality from misdiagnosed and treated calves (Fulton, 2009; Griffin, 1997; Holland et al., 
2010).  The losses from decreased performance and reduced carcass quality were 
reported to account for a greater percentage of the economic loss from BRD than 
monetary investment in treatments costs (Gardner et al., 1999). Improved management 
strategies, such as vaccination and reduced stress, may be used in order to decrease BRD 
incidence rates and recover economic losses attributed to respiratory disease (Step et al., 
2008).  Due to the large impact BRD plays in the beef industry, improved resistance and 
preventive measures against BRD have been important to maintain performance and 
improved health status. 
Bovine Respiratory Disease Symptoms   
  Bovine respiratory disease can have both clinical and sub-clinical symptoms, sub-
clinical symptoms pose difficulties in diagnosis of ill animals. BRD symptoms include: 
nasal or ocular discharge, depression, lethargy, emaciated body condition, labored 
breathing, increased rectal temperature (!39.7°C), or any combination of these symptoms 
(Duff and Galyean, 2007).  However, BRD and other respiratory infection diagnoses 
have been extremely subjective and highly dependent on the observer.  Issues of 
misdiagnosis due to the have been associated with the various symptoms that are often 
associated with other disease. 
Pathogens Contributing to Bovine Respiratory Disease 
Bacterial and viral pathogens have primarily been associated with BRD 
outbreaks; however, this complex disease has not been tied to a single causative agent. 
Pathogens closely associated with BRD infection have been infectious agents that were 
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commonly present in feedlots, including three bacterial pathogens and five viral 
pathogens (Fulton, 2009).  Bacterial pathogens include: Pasteurella haemolytica, 
Pasteurella multocida, and Histophilus somni (Duff and Galyean, 2007; Fulton, 2009; 
Martin et al., 1999; Woolums, 2010).  Viral pathogens that have been closely associated 
with BRD were: infectious bovine rhinotraceitis (IBR), parainfluenza-3 (PI3), bovine 
viral diarrhea virus types 1 and 2 (BVDV), bovine respiratory synctial virus (BRSV) and 
bovine enteric coronavirus (BCV) (Duff and Galyean, 2007; Fulton, 2009; Plummer et 
al., 2004).  Of the associated viral agents, BVDV has recently received more attention 
due to its increased prevalence and association with respiratory disease in feedlot cattle 
(Ridpath et al., 1994).  Bovine viral diarrhea virus has been consistently associated with 
increased BRD risks and lowered performance, specifically affected weight gain in 
feedlot cattle (Martin et al., 1999).  Therefore, improved prevention of BVDV could 
possibly reduce the number of BRD outbreaks that producers’ experience. 
Bovine Viral Diarrhea Virus 
Bovine viral diarrhea virus (BVDV) is a small, enveloped, single-stranded RNA 
virus.  Bovine viral diarrhea virus is a member of the Flaviviridea family and of the 
pestivirus genus (Collett et al., 1988; Kelling, 2004; Moenning, 1990; Ridpath et al., 
1994). Bovine viral diarrhea virus has been grouped into two different sub-types based on 
genotype, type 1 and type 2.  The two subgroups were separated by differences in the 5’ 
UTR region, and therefore animals require antibodies specific to both sub-groups in order 
to be adequately protected from BVDV infection (Ridpath et al., 1994). Not only was 
BVDV sub-divided into two genetically different sub-groups or types, but also both types 
have been sub-categorized into two biotypes, cytopathic and noncytopathic.  Both sub-
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types and biotypes have been found in nature and have been shown to be able to cause 
disease.  Therefore, to fully protect against BVDV infection, vaccines with both type 1 
and 2 strains should be used.  Cytopathic strains affect the cellular structure of host cells, 
while noncytopathic strains do not and therefore have been more challenging to identify 
and isolate (Kelling, 2004).  Both type 1 and 2 strains have been associated with BVDV 
infection, however, clinically severe, acute BVDV infections were caused predominately 
by noncytopathic type 2 strains (Pellerin et al., 1994; Ridpath et al., 1994). 
Bovine viral diarrhea virus can affect the immune, respiratory, reproductive, 
enteric, and endocrine system, which indicates the extent of damage that can be done due 
to the virus (Neill and Ridpath, 2003). BVDV has been observed in 60 to 80% of the 
world, with persistently infected animals reported in one to two percent of those regions 
(Piccinini et al., 2006). To best protect animals against both types 1 and 2, animals should 
be vaccinated with both viral strains of BVDV (Kelling, 2004).  Vaccination is a key 
management tool to prevent BVDV; however, it may not offer complete protection 
against BVDV infection.  
 Bovine viral diarrhea virus has a number of repercussions, associated with itself 
and BRD. These include: acute BVDV infection, secondary infections induced by 
immunosuppression from BVDV infection which often lead to BRD, reproductive 
failure, weak calf syndrome, acute and chronic mucosal disease, and persistent infection 
(Fulton and Burge, 2000; Stokstad and Loken, 2002). Symptoms of acute BVDV include: 
fever, lethargy, loss of appetite, eye and nasal discharge, oral lesions, wheezing, rapid 
breathing, and diarrhea (USDA-APHIS, 2007).   Bovine viral diarrhea virus also plays a 
role in the development of pneumonia and bronchitis as secondary infections that resulted 
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from immunosuppression in the presence of BVDV pathogens (Fulton, 2009). Therefore, 
BVDV has often been associated with pneumonia and bronchitis.  When animals are 
infected with BVDV, the immune system weakens, and there is an increased risk for 
pathogen colonization in the lungs, which can result in respiratory disease (Xue et al., 
2010).   
Similar to BRD, accurate and timely diagnosis of BVDV is challenging (Baker, 
1987).  Many calves die from BVDV infection because they were not identified as ill 
until lethargy had set in. Bovine viral diarrhea virus is not only associated with increased 
incidence of respiratory disease, but also has adverse long-term effects, such as decreased 
fertility rate and lowered production efficiency in cows (Kelling, 2004; Munoz-Zanzi et 
al., 2002).  Numerous problems have been associated with BVDV that negatively impact 
beef cattle production and therefore illustrate the importance of prevention against 
BVDV and other similar pathogens. 
Persistently Infected Cattle 
Animals can become persistently infected when the fetus becomes infected with 
noncytopathic BVDV during the first trimester of gestation (Kelling, 2004; Swasdipan et 
al., 2002). Fetuses exposed to BVDV between 40 and 120 days of gestation may become 
immunotolerant to BVDV. These animals cannot produce antibodies against BVDV and 
therefore they carry and can shed the virus their entire lives (Fray et al., 2000; USDA-
APHIS, 2009b).  BVDV, like a number of other similar viruses, can cross the placenta 
and subsequently undergo viral replication in immuno-deficient fetuses. Once a fetus 
becomes persistently infected with viral RNA, it serves as a viral reservoir for virus 
RNA, which allows newly born animals to rapidly spread infectious diseases (Swasdipan 
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et al., 2001).  Vaccination against BVDV can increase resistance to BVDV infection and 
reduce the frequency of PI animals (USDA-APHIS, 2009b).   
Persistently infected cattle have been of high concern as they continually shed the 
virus and infect other animals. Therefore, PI animals need to be identified at an early age 
and removed to minimize the spread of infectious disease.  There is no “cure” for PI 
carrier animals and therefore, removal of PI animals has been the only way to eradicate 
BVDV persistent infection in a herd. Removal of persistently infected cows and carrier 
calves is a preventative measure for BVDV infection (Kelling, 2004).  Control of BVDV 
prevalence during the cow/calf phase of production has been a preventative step toward 
the reduction of BVDV precursor for BRD. While both cytopathic and noncytopathic 
biotypes of BVDV cause disease in cattle, PI animals tend to be infected with 
noncytopathic BVDV strains (Kelling, 2004).  
Prevalence of BVDV PI animals has been surveyed in US cattle herds.  To 
accomplish this, ear samples from 44,150 BVDV infected animals were collected and 
analyzed for PI animals in the most prevalent beef producing states (USDA-APHIS, 
2009b).    Prevalence of persistently infected animals was observed at 0.12% among 
animals tested, but within a herd PI prevalence ranged from zero to 16% (USDA-APHIS, 
2009b).  While the prevalence of BVDV PI in the USDA-APHIS (2009b) study from 
2007 appeared low, approximately one in 12 operations had at least one PI calf (USDA-
APHIS, 2009b).  This indicated that in BVDV infected herds BVDV PI carriers 
continually infect new animals, which shed the virus, which increases the risk of 
perpetually infecting additional cattle.  
Economic Impacts 
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 Bovine viral diarrhea virus infection has economic ramifications for the beef 
cattle industry as it results in a number of clinical diseases that adversely affect all phases 
of the production cycle.  Effects of BVDV range from persistently infected (PI) animals, 
to reproductive failure, to respiratory disease (Kelling, 2004).  There have been 
preventive methods that have been implemented, such as vaccination and management 
strategies, to reduce disease incidence.  Bovine viral diarrhea virus infection can be 
transmitted vertically or horizontally through inhalation or ingestion of infected body 
secretions or excretion.  Infection of pregnant cows has been of great concern, as a cow 
can transmit the virus to the fetus via transplacental infection, which creates PI animals 
(Kelling, 2004).  The continued transfer of BVDV contributes to the financial drain from 
infectious disease on beef producers. 
Persistently infected calves were one of the largest contributors to economic 
losses attributed to BVDV.  Removal of PI calves from herds has been estimated to 
increase the value of uninfected animals that remain in the herd by $22.70 (USDA-
APHIS, 2009a).  Not only can PI calves affect the value of non-infected calves, but 
negative effects from exposure to PI calves were also observed on performance traits in 
feedlot cattle.  Persistently infected calves gained less weight through day 28 of feedlot 
arrival, but differences in weight gain had disappeared by day 56.  In the first 28 days of 
feedlot arrival, PI-exposed calves had a 4.1% reduction in ADG compared to control 
calves (non-exposed), which indicated that control calves were not combating sub-
clinical symptoms during the early feedlot phases (Elam et al., 2008).  Therefore, 
identification of PI claves prior to feedlot shipment can improve an animal’s performance 
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in the growing and finishing phases, and result in increased value in non-infected cattle as 
well. 
Treatment of infected animals can be more expensive than the cost of prevention 
through vaccination and controlled management. However, some producers simply do 
not vaccinate animals for any disease (Powell et al., 2010).  While preventive measures 
may be costly, vaccination programs have an estimated cost of three to ten dollars per 
cow/calf unit which has been less than the estimated treatment costs (Powell et al., 2010).  
Vaccination and preconditioning programs have been shown to offer financial benefits. 
Cow/calf producers have seen increased returns of up to $14 per head when a 
vaccination/preconditioning management program was implemented.  Return on this 
investment was influenced by time of sale (season) and animal weight (Dhuyvetter et al., 
2005).  Additionally, feedlot producers have seen financial benefits as well, with returns 
ranging from $40 to $60, depending on the quality and integrity of the preconditioning 
program.  Feedlot producers were also able to benefit from the increased premiums paid 
for vaccinated and preconditioned feeder calves (Dhuyvetter et al., 2005). 
Bovine Respiratory Disease Effects on Performance and Carcass Traits 
While there have been estimates for BRD disease incidence, diagnosis of BRD in 
feedlot cattle continues to be a challenge and these estimates were often invalid, as a 
large percentage of animals were not properly diagnosed. Schneider et al. (2009) reported 
that lung lesions appeared in 60.6% of untreated cattle for BRD.  This finding indicates 
that current observation methods for diagnosis in feedlots may ineffectively characterize 
infected animals, as there were a number of animals that suffered from sub-clinical 
symptoms that were never identified as infected based on lung lesions.  Although, in the 
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same study, 26% of treated cattle did not show lung lesions, which indicated that proper 
treatment may prevent or minimize damage to lungs of infected cattle (Schneider et al., 
2009).  The 26% of cattle that did not have lung lesions may have also been 
misdiagnosed during lung lesion scoring.  As identification and scoring of lung lesions in 
the packing plant was subjective to both the scorer and placement or position of the lung 
on the conveyer belt.  Additionally, it illustrated the difficulty in respiratory disease 
diagnosis, highlighting the variable states the disease can be found in and the subjectivity 
of diagnosis. Therefore, lung lesion presence may not be the most accurate identification 
method of infected animals at harvest.   
BRD has been associated with reduced performance traits: lower body weight and 
reduced gain.  Schneider et al. (2009) reported that BRD affected both acclimation and 
overall ADG, with the greatest affect observed during the acclimation period.  This 
indicates that cattle suffer the greatest performance losses shortly after entry into the 
feedlot.  Similarly, as number of treatments for BRD increased, ADG during the 
backgrounding phase decreased.  Furthermore, animals that were treated two or more 
times experienced 12% lower ADG though the first 67 days in the feedlot (Roeber et al., 
2001).  Thus, disease incidence can have negative repercussions on feedlot performance. 
Not only does infection and treatment affect animal performance, animals that 
become infected three or more times have been shown to produce lower-quality 
carcasses.  The number of treatments an animal undergoes has been shown to affect dry 
matter intake, ADG, hot carcass weight, subcutaneous fat cover, and yield grade (Gardner 
et al., 1999; Holland et al., 2010; Schneider et al., 2009).  Animals that were treated two 
or more times had significantly reduced hot carcass weight by three percent, lower 
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dressing percentages, lower adjusted fat thickness and USDA yield grade, as compared to 
non-treated animals (Roeber et al., 2001).  Therefore, prevention and early diagnosis have 
been important to help minimize the economic losses attributed to BRD. 
Maternal Antibodies 
Maternal antibodies are the first line of defense against infectious pathogens in 
newborn calves. Maternal antibodies are transferred through the colostrum from the dam 
to calf (Roth, 2008). Colostrum quantity and quality is highly variable from cow to cow, 
herd to herd, season to season, and year to year (Cortese et al., 1998; Munoz-Zanzi et al., 
2002). The presence of high concentrations of quality passive antibodies acquired 
through the colostrum has been shown to be essential for reduced susceptibility to 
infectious agents, including those closely associated with respiratory diseases prior to 
immune development.  Animals who consume inadequate amounts of colostrum have 
been shown to have increased risks for disease while the immune system was immature 
(Perino and Wittum, 1995).  Passively acquired antibodies have also been shown to be 
important for promotion of overall herd immunity and decreased disease incidence. 
Furthermore, as passive immunity decays over time, the susceptibility to disease will 
reciprocally increase over time.  Thus, in order to maintain protective antibody levels 
there is a need to vaccinate young calves against infectious pathogens to prevent infection 
(Munoz-Zanzi et al., 2002).  
 Factors that affect colostral immunoglobulin transfer in calves at 10 and 24 hours 
post calving were evaluated, specifically plasma protein and IgG concentrations.  Calf 
sex, dam body condition score, and calf birth weight were not associated with the 
acquired immunoglobulin concentrations (Perino and Wittum, 1995).  Calves that were 
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stressed at birth, when models were unadjusted for dam age or presence of mastitis, had 
lower immunoglobulin concentrations compared to animals that were not stressed at 
calving.  However, once immunoglobulin levels were adjusted for dam age and mastitis 
no significant difference was seen in immunoglobulin levels (Perino and Wittum, 1995).  
Immunoglobulin levels in calves born to two-year-old dams were lower than for calves 
that were born to older cows.  However, colostral immunoglobulin levels were not 
affected by dam age (Perino and Wittum, 1995).  There also appears to be a seasonal 
affect on serum immunoglobulin levels, where calves born later in the season had both 
lower serum and colostral immunoglobulin levels available (Perino and Wittum, 1995). 
 The rate of antibody decay was highly dependent on the amount of maternally 
derived antibodies and antibody types (Munoz-Zanzi et al., 2002).  Research indicated 
that maternally derived antibodies begin to decay as early as two days of age; however, 
the age at which antibody levels become undetectable was highly variable and dependent 
on the amount of maternally acquired antibodies (Fulton et al., 2004).  This variation has 
been illustrated in a number of studies, where the decay to undetectable levels of BVDV 
maternal antibodies in calves range from 105 to 230 days of age (Kendrick and Franti, 
1974; McGuire et al., 1976; Menanteau-Horta et al., 1985).  In a study by Munoz-Zanzi 
et al. (2002), 466 dairy calves were evaluated for maternal BVDV antibody decline.  Rate 
of decay to seronegative level was variable between BVDV types 1 and 2 antibodies. 
Seronegative was defined as BVDV antibody titer less than 1:16. Significant differences 
in rate of decay were evaluated on the number of days to reach the seronegative point. 
BVDV type 2 antibody titers decay faster than BVDV type 1 antibody titers. Munoz-Zani 
et al. (2002) predicted that type 1 antibodies would reach a seronegative titer between 
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139 or 143 days of age depending on the herd.  In contrast, BVDV type 2 antibody titers 
were predicted to regress to seronegative levels by 118 or 110 days.  In an additional 
analysis, the total amount of passively acquired antibodies affected the number of days it 
took for antibody titer to become seronegative.  Calves with a maternal antibody peak 
titer of 1:512 had an estimated age of 131 days to reach seronegative levels, compared to 
calves with a peak maternal titer of 1:32 with an estimated age of 74 days to reach 
seronegative levels (Munoz-Zanzi et al., 2002). Animals that have serum antibody titers 
greater than zero at day zero will prevent antibody seroconversion from day zero to day 
116 (Fulton et al., 2004).  However, the age at which animals begin to seroconvert may 
be dependent on the herd, immunity status of animals, and the amount of passively 
transferred antibodies. The duration of protection against foreign pathogens from passive 
antibodies was dependent on day zero antibody titers and the immune status of the dam 
that transferred the passive anitbodies.  Detectable level of BVDV2 antibodies in calves 
at day zero was 1:128; however, just because day zero titer was below this threshold did 
not guarantee seroreversion in all animals (Fulton et al., 2004).  Zimmerman et al. (2006) 
reported that the age when calves reach seronegative levels of passive antibodies was 
highly variable by herd, antibody type, dam’s immunological status, and quantity of 
passively transferred antibodies. 
 Maternal antibodies have numerous benefits. Advantages from maternal 
antibodies may also play an important role in the development of long-term immunity 
and health status of animals (Wittum and Perrino, 1995).  However, circulating maternal 
antibodies at vaccination may adversely affect an animals’ ability to respond to 
vaccination and the efficacy of the vaccine (Ellis et al., 2001; Fulton et al., 2004; Kelling, 
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2004; Munoz-Zanzi et al., 2002; Roth, 2008; Zimmerman et al., 2006).  While, maternal 
antibodies protect naïve calves from infectious pathogens, when present at the time of 
vaccination, these same maternal antibodies may neutralize the antigen presented by the 
vaccine and thereby prevent an immune response in calves (Zimmerman et al., 2006).  
There have been two strategies that have been proposed to overcome the interference of 
maternal antibodies.  First, delay vaccination until passively acquired maternal antibodies 
have declined below maternal threshold levels or second, increase the vaccine dosage 
(Hamers et al., 2007).   
 It has been well documented that maternal antibodies inhibit acquired antibody 
response to vaccination (Funnell, 2011; Munoz-Zanzi et al., 2002; Roth, 2008; 
Zimmerman et al., 2006).  Therefore, maternal antibodies must regress below a level that 
does not interfere with the immune response to vaccines to benefit from vaccinations.  
When maternal antibodies drop below a protective threshold, there is a period of 
vulnerability during which time calves have an increased susceptibility to disease 
(Funnell, 2011).  Data indicates that once passive antibody titers were ! 1: 16, calves 
have increased susceptibility to clinical BVDV infection. Therefore, there appears to be a 
small window of opportunity during which maternal antibody levels fall below the 
maternal threshold (1:32), but are still high enough that calves are protected from 
infectious pathogens (Funnell, 2011; Munoz-Zanzi et al., 2002).  Unfortunately, this 
window of opportunity is not identical for every calf, and therefore vaccination protocols 
need to account for differences in maternal antibodies levels. 
Respiratory Disease Prevention 
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Reductions in respiratory disease may be associated with a number of various 
preventative methods and management practices that occur simultaneously and interact 
with one another. These interactions may enhance or deter the expected outcome from 
various prevention methods.  Some commonly used tools for prevention include: prenatal 
health through dam vaccinations, removal of disease carriers, isolation of animals prior to 
herd introduction, isolation of diagnoses and/or treated animals, vaccination, 
backgrounding, and/or preconditioning.   Most often a combination of preventative 
methods and practices offer the greatest protection and enhanced performance. 
Vaccination 
Vaccination has been used as a primary method for prevention of both respiratory 
diseases and the viral pathogens associated with BRD. Specifically, vaccination has been 
one of the most important methods for prevention of BVDV infection and maintenance of 
healthy herds (Kirkpatrick et al., 2008; USDA-APHIS, 2009d; Zimmerman et al., 2006). 
Vaccination has been a management tool that helped animals develop their specific 
immune system through acquired antibody production. Vaccination has been shown to 
improve animal health and productivity by reduction in disease incidence as animals 
move through production phases (Kirkpatrick et al., 2008). Maternal antibodies offered 
protection to animals while the immune system was immature, however the presence of 
maternal antibodies at vaccination can inhibit the development of the specific immunity.  
The lag period between innate and specific immunity development often occurs during 
periods of high stress such as: weaning, transportation, comingling, or feedlot transition 
(Duff and Galyean, 2007; Guide, 2000; Niekamp et al., 2007; Salak-Johnson and 
McGlone, 2007).  Therefore, if vaccination occurs before or after weaning and prior to 
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feedlot transportation, the immune system was primed prior to high stress periods and the 
increased presence of foreign pathogens, thus infection risks were decreased. 
It has been shown that vaccination of weaned cattle prior to arrival into the feedlot 
can prevent infectious diseases that may lead to the onset of BRD (Kirkpatrick et al., 
2008).   While the practice of vaccination has been adopted in many production systems, 
a protective response from the vaccines must be achieved for disease prevention.  High 
stress, poor nutrition, and improper vaccination administration can alter immune response 
(Duff and Galyean, 2007; Salak-Johnson and McGlone, 2007).  Therefore, the goal with 
any vaccination program has been to elicit an immune response to those pathogens 
present in the vaccine (Funnell, 2011). However, measuring vaccine efficacy has been a 
challenge and has often been centered around neutralizing antibody levels (Potgieter, 
1995).  Vaccination has been a method of priming the immune system prior to infectious 
pathogen exposure, which helps the immune system to respond faster when challenged 
with pathogens.   
In a study by Platt et al. (2009), calves were vaccinated with a five-way vaccine at 
either 1) one to two, 2) four to five, or 3) seven to eight weeks of age, vaccinated animals 
had a significantly higher BVDV antibody response compared to non-vaccinated animals.  
Titers for BVDV type 2 declined over a twelve-week period, regardless of vaccination 
status. However, when challenged with the infectious pathogen, animals that were 
vaccinated at: four or five weeks and seven or eight weeks, had significantly higher 
antibody responses compared to controls (unvaccinated).  Calves vaccinated at four or 
five weeks or seven or eight weeks also had significantly higher titers than those animals 
that were vaccinated at one to two weeks (Platt et al., 2009).  This study indicated that it 
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might be possible to vaccinate animals too young, at a time when their innate immune 
system was too robust to allow specific immunity development.  If preweaning 
vaccination was not feasible, then vaccination at weaning and booster administered 14 to 
21 days later was a recommended protocol from the Value Added Program (Duff and 
Galyean, 2007).  Thus, vaccination prior to shipment has been shown to be beneficial in 
disease reduction even during high stress periods such as weaning. 
Vaccination programs may not offer complete protection against BVDV infection, 
and vaccination should not solely be relied on for the prevention of respiratory infection 
or associated pathogens (Campen et al., 2000).  Vaccination in conjunction with good 
management practices such as: decreased stress, good innate immunity, and adequate 
nutrition, may help increase the response to vaccination and improve disease prevention 
(Bagley, 2001).  In a study by Salt et al. (2007), clinical signs for Bovine herpesvirus 1 in 
vaccinated animals were reduced. Bovine heresvirus 1 clinical signs lasted for 10 days in 
vaccinated calves in comparison to 14 days for unvaccinated calves.  However, no 
differences were observed for BVDV antibody levels in vaccinated versus non-
vaccinated animals. In addition, vaccinated calves, when challenged with BRSV, showed 
less severe signs and clinical signs were observed for a shorter period of time in 
comparison to non-vaccinated calves (Salt et al., 2007).  This indicated that not all 
animals were able to respond to all viral pathogens present in the vaccine equally and that 
vaccination alone may not offer complete protection against diseases. Additionally, 
vaccinated calves, regardless of their response to individual vaccine components, were 
less vulnerable to secondary infections, which reduced the likelihood of BRD incidence. 
!!
"*!
The immune system must be activated in order for vaccination to be a beneficial 
management practice and to prevent disease.  Additionally, maintained immunity to 
BVDV or other BRD associated pathogens has been an important aspect of prevention 
and protection against BRD.  Advantages in the duration of the immune system were 
seen for antibody production to modified-live vaccines, as they produced a stronger 
antibody response at initial exposures and therefore require fewer exposures than 
inactivated vaccines to achieve similar antibody responses (Fulton and Burge, 2000; 
Kelling, 2004).   
While research showed that vaccination offers many benefits to producers at all 
phases, a study by the USDA-APHIS (2009c) showed 61.6% of operations vaccinate 
calves from 22 days of age to weaning. Surprisingly, only one-third of operations 
vaccinate calves in this same age range for respiratory pathogens.  While larger 
operations were more likely to vaccinate calves in comparison to smaller operations 
(USDA-APHIS, 2009c). This same study showed that 63.2% of calves from operations 
with one to 49 cows were not vaccinated for respiratory pathogens compared to 
operations with 200 or more cows that reported only 11.9% of calves were not vaccinated 
against respiratory pathogens.  In addition, USDA-APHIS (2009d) conducted a 
vaccination practices study in 2007-2008 in 24 major beef producing states.  As found in 
the previous study, 69.4% of operations vaccinated cows or calves of any age in 2007. 
Larger operations, of 50 or more cows, were more likely to vaccinate beef cattle in 
comparison to smaller operations (>50 head) (USDA-APHIS, 2009d). Of those 
pathogens that were vaccination against, BVDV was the second most commonly 
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administered vaccination to cattle behind Leptospira, 27.8% of operations vaccinate cattle 
against BVDV (USDA-APHIS, 2009d).   
Vaccination Timing 
Efficacy of vaccines has been shown to be highly variable, with response to 
vaccination dependent on age and immune status of the animal at the time of vaccination.  
Vaccine efficacy was also dependent on dose of the virus administered, the particular 
viral strain used, and the presence or absence of viral or bacterial infections in the host 
(Engelken, 1997).   Timing of administration and cow age at vaccination against 
respiratory pathogens was highly associated with the effectiveness of preconditioning, as 
well as the effectiveness of vaccination management (USDA-APHIS, 2009c). Richeson 
et al. (2009), observed a vaccination by timing of administration interaction.  Animals 
that were treated with Clostidial upon arrival, followed by a delayed (14 days) respiratory 
vaccination, had significantly more chronically ill animals than those who received both 
vaccinations at the same time, either both upon arrival or both administered at a delayed 
time (14 days) (Richeson et al., 2009). Sixty-nine percent of all calves were treated for 
BRD at least once regardless of the vaccination administration timing. 
 Designing a protocol that designates a specific age for calve vaccination, in order 
to achieve 100% response, has not been feasible (Fulton et al., 2004).  Nevertheless, age 
at weaning for vaccination has been shown to have a significant affect on respiratory 
disease incidence (Stilwell et al., 2008).  But age was a highly variable factor in 
vaccination protocol design, as the age to vaccinate calves was dependent on dam age, 
immune status of the dam, quantity and quality of passive antibodies, and specific 
antibody decay rates.  Based on an analysis, which used odds ratio, animals that were 
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weaned at an older age were less likely to show respiratory infection (Stilwell et al., 
2008).  This indicates that animals vaccinated at older ages were more likely to respond 
to the vaccine. 
Optimization of vaccination protocols in order to decrease disease prevalence may 
reduce economic losses. Although protocol optimization may vary by region, disease 
exposure, facilities, and herd specificity (USDA-APHIS, 2009d).  There have been 
numerous environmental factors identified that can affect response to vaccination and 
protocol design, such as: year, season, nutrition, cow variation, and concurrent disease 
pathogens (Bagley, 2001; USDA-APHIS, 2009d).  However, even when in a controlled 
environment, vaccines will not be 100% effective on all animals (Bagley, 2001). 
Indicating that there may be a genetic contribution.  It has been demonstrated that with 
optimal nutrients and well-managed early calf development that the immunity of animals 
can be improved through proper vaccination methods. 
 Research indicated that operations would benefit from immunization programs 
both financially and through improved animal health. However, vaccination protocols 
may need to be developed for individual operations (USDA-APHIS, 2009d).  These 
vaccination protocols will need to account for management practices specific to each 
operation. Protocols may vary for fall versus spring calving herds, differences in cow 
immunity and age, or stressors that a calf experiences at vaccination, such as weaning or 
transportation.  Vaccination has often been considered costly, nevertheless it has been 
shown to be an effective risk management tool and offers premiums to producers who 
have documented vaccination management practices (Duff and Galyean, 2007; USDA-
APHIS, 2009d). 
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Preconditioning  
Another prevention method that has been incorporated in management practices 
by producers was preconditioning of calves.  Preconditioning may include, but was not 
limited to: vaccination, weaning, dehorning, bunk breaking, castration, and 30 to 45 day 
backgrounding (Duff and Galyean, 2007). Preconditioned calves that weighed less than 
318 kg exhibited an increased performance and decreased morbidity and mortality in 
early feedlot phases (USDA-APHIS, 2000).  Additionally, improvement of pre- and post-
weaning environment and management conditions can be done by: minimized stress, 
proper vaccination, adequate nutrition, colostrum consumption, and removal of diseased 
animals (Duff and Galyean, 2007; Salak-Johnson, 2007; Salt et al., 2007). While there 
were management variations in preconditioning methods used by producers, 
preconditioning as a preventative method was shown to reduce disease incidence and 
BRD morbidity.  
Cattle that were managed on a preconditioning program, which included 
documented vaccination, had reduced morbidity and mortality rates, 34.7 to 36.7% and 
1.1%, respectively.  Morbidity and mortality rates were significantly greater in animals 
that were not managed under a vaccination preconditioning protocol, with 77.3% and 
11.1%, morbidity and morality rates, respectively (Roeber et al., 2001).  Therefore, 
animals that were preconditioned and vaccinated for respiratory pathogens had 
significantly fewer treatments per animal, which resulted in fewer losses.  Additionally, 
no significant differences were seen in live weight or overall ADG, which indicated that 
animals with strengthened immune systems from vaccination did not have reduced 
performance (Roeber et al., 2001).  Therefore, successful vaccination and preconditioning 
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programs may reduce BRD incidents and minimize associated costs without negatively 
affecting performance. 
In a study, which evaluated the effects of: weaning stress, comingling stress, and 
vaccination, animals that were not preconditioned had a significantly greater proportion 
of calves that required three or more respiratory treatments.  Additionally, animals that 
were not preconditioned or experienced comingling stress at marketing, required 
treatments significantly earlier than animals that were vaccinated prior to feedlot entry 
(Step et al., 2008).  Therefore, animals that experience comingling and weaning stress 
prior to feedlot entry were less likely to be become ill and treated.  Additionally, animals 
that experienced less stress (pre-weaned upon feedlot entry) when they were vaccinated 
at feedlot entry had increased opportunity to respond to the vaccinations.  
Immune Response 
Immune response is regulated by both innate and active immunity.  The innate 
immunity is for non-specific and active immunity if for specific, the two immune 
responses work together to prevent diseases (Chase et al., 2004).  The active immune 
system has been divided into passively acquired antibodies that are transferred from the 
cow to the calf through colostrum ingestion and absorption and adaptively acquired 
antibodies that are developed through pathogen exposure, often vaccination (Fulton et al., 
2004).  While innate immunity has been the initial protection in newborn animals against 
infectious pathogens, its effects are short term and animals develop an increased 
susceptibility to disease over time as passive antibodies decay.  Therefore, adaptive 
specific immunity must be developed in order to provide further protection against 
infectious pathogens. The specific immune response has been divided into cellular and 
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humoral immunity, which have individual cell types, T-helper 1 (THI) and T-helper 2 
(TH2), that are associated with specificity of immune response.  T-helper 1 cells are 
associated with the cellular immunity activation and Th2 cells are associated with 
humoral immune activation (Elenkov, 1999).  Humoral immune response is needed for 
viral clearance. 
The immune system has been characterized as a mechanism that organisms use to 
defend against infectious agents and foreign pathogens. The highly complex immune 
system plays an integral part in all other systems and organs within the body. The main 
purpose of immune activation has been to inactivate free virus particles and eliminate 
infected cells that could release infectious viral particles (Husband and Lascelles, 1975).  
Immunoglobulins were known to neutralize BVDV infectivity and induce cell-mediated 
immunity, specifically CD4+, which was important for protection against acute infection 
with noncytopathic strains of BVDV type 2 (Collen and Morrison, 2000; Rhodes et al., 
1999). 
 The immune system can be activated through natural pathogen exposure and 
management tools such as vaccination. Vaccination has been used to stimulate a humoral 
immune response in animals.  However, there are numerous types of vaccines available, 
each of which stimulates the immune response differently. Intranasal immunization may 
be more likely to stimulate the immune system in the presence of circulating maternal 
antibodies in comparison to modified-live or killed vaccines (Ellis et al., 2007). 
Modified-life vaccines appear to act as immunosuppressants when used in the presence of 
stress and do not elicit as robust immune response in comparison to inactivated vaccines 
that were less immunosuppressive (Roth and Kaeberle, 1982).  Thus, the type of 
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stimulant used to initiate an immune response changes the type and strength of the 
observed response. 
A number of preweaning and postweaning factors have been identified that could 
adversely affect the immunity development in an animal.  Improved immune protection, 
through prenatal protection and vaccination, may be preventative for BRD incidence 
(Duff and Galyean, 2007).  However, there were a number of factors that must be 
considered when evaluating immune response.  Stress factors such as: weaning; 
marketing; transportation; nutrition; genetics and health history, to viral and bacterial 
pathogens, could all affect the immune status of an animal and drain the immune system, 
which results in an increased disease risk in stressed animals. Factors known to activate 
the immune system, such as prenatal nutrition, colostrum, and preconditioning 
management factors need to be considered as well (Duff and Galyean, 2007).  Therefore, 
prevention against infectious agents alone may not be enough to prevent BRD, but 
through reduced stress and improved herd health status resistance to BRD may be 
increased.   
The immune and growth systems appear to be controlled by many of the same 
regulators. Cytokines that were once identified as immune modulators, such as: 
glucocorticoids, prostaglandins, and catecholamins, have also been found to be important 
for cell metabolism and growth (Spurlock, 1997).  Therefore, stimulation of the immune 
system or stress on the immune system may suppress the growth of animals and has been 
a concern for animal performance (Spurlock, 1997).  Reallocation of nutrients and energy 
resources has been associated with increased up-regulation of the immune system. 
Therefore, identification of immune thresholds that were needed to maintain healthy 
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status may offer minimized growth losses that could occur due to an over activated 
immune system and reallocated energy resources from performance to immune response.   
Antibodies have the ability to protect against viral infection and prevent 
development of long-term virus infection. However, the protection provided from the 
vaccine response was dependent on the strain of the virus administered in the vaccine, 
along with the level and the isotype of antibodies produced (Chase et al., 2004).  While 
antibodies have been a vital part of the immune system, they were simply an indicator of 
the presence of an immune response. They were not an indicator of how protective the 
immune response was (Chase et al., 2004).  Increased antibody levels may be more of an 
indication of increased vaccinations and/or field exposure to pathogens, rather than 
increased protection to infection pathogens (Fredriksen et al., 1999). Antigen presenting 
cells were essential for introduction and controlling the viral immune response (Chase et 
al., 2004).  The antigen presenting cells identify foreign antigens and then present the 
antigen to the T helper cells for recognition. Specific antibodies were then developed as a 
protection measure in the event that the animal was exposed the pathogen again (Chase et 
al., 2004). 
 Vaccinations have been designed to specifically to target macrophages, B 
lymphocytes, and T lymphocytes (Funnell, 2011; Kelling, 2004).  The B-lymphocytes 
were extremely important for the production of acquired antibodies. The marcrophages 
present antigens to the B lymphocytes and recognition for memory cells takes place. 
Once these lymphocytes were able to recognize the antigen, specific antibodies for that 
pathogen could be made (Funnell, 2011). Viruses have been shown to suppress the cell-
mediated immunity of B and T-cells, which allows for infection (Piccinini et al., 2006). T 
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lymphocytes also have had key roles in immune response, with two distinct 
classifications within the T-cell populations.  One group of T-cells act similar to 
macrophages in the identification and presentation of antigens and the second 
classification of T-cells act to destroy infected host cells before viral replication can be 
completed (Funnell, 2011). The specificity within the immune system was similar to that 
within the endocrine system, the different cells act as hormones to regulate the desired 
response. 
Numerous studies have evaluated the effects of immune stimulation through 
vaccination protocols on growth (Duff et al., 2000; Richeson et al., 2008; Richeson et al., 
2009).  These studies present many conflicting results of immune response to vaccination 
on growth and ADG.  Richeson et al. (2009) observed no differences in ADG between 
four different vaccination protocols, in which calves were vaccinated with colostridial 
and respiratory vaccines at arrival or delayed (14 days) time points in the feedlot.  
However, in the Richeson et al. study from 2008, calves that received a delayed 
modified-live vaccination expressed greater ADG than calves that received the 
vaccination upon arrival.  Duff et al. (2000) showed no significant difference in growth 
between four vaccination protocols, where some calves received no vaccination and 
others received various vaccination treatments in the feedlot. However, Kreikemeier et al. 
(1996) observed that calves vaccinated with killed-virus for BRD on farm and again 
during comingling at the sale barn had increased growth in the 21 day receiving period 
into the feedlot in comparison to calves that were given a modified live vaccine upon 
arrival in the feedlot and revaccinated 21 days later (Kreikemeier et al., 1996). These 
conflicting results for ADG and growth may be due to a number of factors including: 
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environment (year, season, climate), breed, innate immunity, age, immune status at 
vaccination, vaccination type, vaccination history, and nutrition availability. 
Additionally, there appears to be some evidence for increased performance from calves 
vaccinated prior to feedlot arrival in comparison to calves vaccinated at the feedlot. 
 Immune function may be compromised during periods of high stress (Richeson et 
al., 2008).  High stress periods have been shown to cause immunosuppression, which 
may cause reduced vaccine efficacy and calf performance (Richeson et al., 2008; Salak-
Johnson and McGlone, 2007).  The negative effects from stress on the immune system 
were often emphasized during periods of high stress, as animals were often exposed to 
infectious pathogens which caused reduced immunity and increased susceptibility 
(Blecha et al., 1984).  This immunosuppression that has been caused by BVDV may be 
associated with reduced interferon response and elevated transforming growth factor-" 
levels (Charleston et al., 2001).  Therefore, minimized stress offered the most optimal 
state for immune activation. 
Stress Effects 
The interaction between immune and stress systems was complex and influenced 
by numerous factors.  Response to stress has been variable between individual animals 
and was influenced by a number of environmental and management factors.  An animal’s 
responsiveness to stress has often been controlled by social status, age, genetics, type of 
stressor, and the duration of the stressor (Salak-Johnson and McGlone, 2007).  
Additionally, stress shifts the TH1/TH2 balance in calves and may prevent the return to 
T-cell homeostasis. An unbalanced immune system does not respond adequately or 
timely to pathogens and disease often results (Elenkov, 1999).  The balance between TH1 
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and TH2 has been very important for immune response, for the recognition of antigens 
and for viral clearance.  Therefore, stress, such as weaning, alters the TH1/TH2 balance 
and prevents not only response to pathogens, but also the response to vaccination. 
 Stress has been shown to suppressed the immune system and increase disease 
susceptibility in animals, thus increased disease incidence during periods of high stress 
(Blecha et al., 1984; Salak-Johnson and McGlone, 2007).  Stressor types and individual 
response to stress tend to affect the immune response differently for every animal, with 
the immune system more severly suppressed by chronic stressors (Salak-Johnson and 
McGlone, 2007).  Stress is associated with mediating hormone levels and the increased 
release of hormones such as glucocorticoids, which play a pivotal role in an animal’s 
response to stress (Salak-Johnson and McGlone, 2007).  When hormones are out of 
balance as a response to stress, the development of TH1/TH2 cells or antibodies in 
response to vaccination is a challenge and often lowers the response of the immune 
system. 
Suppression of the immune system due to stress also inhibits antibody response 
(Duff and Galyean, 2007; Salak-Johnson and McGlone, 2007).  Richeson et al. (2009), 
evaluated cortisol concentrations as an indicator of stress on calves and its effects with 
vaccination treatments. Differences in vaccination treatment times (arrive or delayed 
vaccination times) were evaluated, however the most significant observation was a 
difference in day affect of cortisol levels.  Cortisol concentrations were highest at day 
zero (3.04 µg/100mL) and declined through day 14 (2.43 µg/100mL), but by day 28 
concentrations were increased (2.57 µg/100mL), which indicated presence of a new stress 
or possible measurement error.  This indicated that physiological stress was the greatest 
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during the first 14 days of the receiving period, which has also been identified as a 
critical time for BRD outbreaks (Richeson et al., 2009).  Due to increased stress levels 
animals may be more susceptible to disease, specifically respiratory disease, during the 
first 14 days upon arrival into the feedlot.  Although, Richeson et al. (2009) results did 
not show affects on vaccination response due to cortisol levels, other studies have shown 
that stress can suppress the immune system and inhibit response to vaccination (Elenkov, 
1999; Funnell, 2011; Niekamp et al., 2007; Salak-Johnson and McGlone, 2007).  
Additionally, in a study by Blecha et al. (1984), increased cortisol levels were not 
correlated with immunosuppression, which suggests that cortisol may not be the most 
effective method to measure the presence of stress or its effects on the immune response.  
While cortisol levels may not be correlated with immunosupression, this does not 
eliminate the possibility that stress negatively affects immune response, as cortisol 
represents only one hormone that may be up regulated with stress.  This only indicated 
that increased cortisol concentrations do not have interactions with antibody development 
to these vaccines.  
 Bovine respiratory disease onset seems to be most crucial during the first 30 days 
after weaning and first 14 days upon feedlot arrival. Both of these periods have been 
identified as high stress periods.  Furthermore, stress has been shown to weaken the 
immune system. Therefore, it is plausible that susceptibility to BRD is increased during 
these periods of high stress (Holland et al., 2010; Step et al., 2008).  The greatest number 
of BRD treatments occur within the first two weeks of arrival into the feedlot, which 
indicates that preventative measures prior to feedlot introduction may assist in the 
minimization of BRD occurrence (Babcock et al., 2009). These high-risk periods have 
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been viewed as a critical time for BRD prevention in animals. While calves are routinely 
vaccinated upon arrival at the feedlot, it is possible that this practice is too late to prevent 
the majority of BRD incidence.     
 Calves at the highest risk for BRD were calves that have previously experienced 
BRD infection or have had a weakened immune system due to viral infections associated 
with BRD (Fels-Klerx et al., 2000).  Additionally, in a dairy calf study, season of birth 
and presentation of quality colostrum were identified as key management factors that 
affect BRD outbreaks, specifically pneumonia, in young calves (0-3 months) (Fels-Klerx 
et al., 2000).  Early prevention through passively transferred antibodies has been 
important for reduced BRD incidence in young calves that have immature immune 
systems.  Passively acquired antibodies help protect against BRD incidence and help in 
the transition from innate immune protection to specific immune protection. 
 There were a number of management and environmental stressors that affect 
BRD, some of these stressors include: weaning, castration, dehorning, bunk breaking, 
transition stress, comingling, social status disruption, feed changes, heat/cold stress, 
environmental changes, and pathogen challenges (Salak-Johnson and McGlone, 2007).  
Stress duration varied with the type of stress and the age when stress was experienced. 
Transportation stress has been shown to peak at day 15 post feedlot arrival based on 
hemolytic complementation concentrations (Purdy et al., 2000).  Immunoconglutinin 
titers peaked at 15 days post feedlot arrival, while M haemolytic concentrations were not 
observed to peak until day 28.  There was a two week lag period between peak antibody 
levels specific to the infectious bacterial pathogen associated with BRD (Purdy et al., 
2000).  Therefore, due to increased stress response at feedlot arrival, vaccines 
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administered at feedlot arrival may not be effective or have reduced efficacy in stressed 
cattle.   
Weaning 
 The breaking of the maternal and offspring bond has been identified as a stressful 
time in both calves and piglets (Hickey et al., 2003; Niekamp et al., 2007).  Weaning can 
cause abrupt changes in social status, nutrition, and environment of animals, which all 
may prevent the return to homeostasis of TH1/TH2 cells and other hormones. This has 
been shown to suppress an animal’s immune response, by either preventing the response 
to vaccines or increased disease susceptibility (Niekamp et al., 2007).   
 In a porcine study, the age at weaning was seen to have significant effects on 
ADG and mortality rates in the nursery (Main et al., 2004).  Additionally, the age at 
weaning was shown to significantly influence leukocyte populations.  In pigs, 
lymphocyte counts increased with age of the piglet, but neutrophil counts, IgG 
concentration, and mitogen-induced B-cell proliferation decreased (Main et al., 2004).  
This demonstrated that when pigs were weaned at an older age they may have a more 
developed immune system, and were more capable of mounting an adequate immune 
response when challenged with pathogens during times of high stress (Main et al., 2004).  
Piglets with developed immune systems at weaning had more desirable growth and 
performance, which resulted in healthier, heavier pigs.  Main et al. (2004) also suggested 
that pigs with a less developed immune system at weaning would aliquot more resources 
to immune system activation and maintenance than growth, which resulted in poorer 
performance. Purdy et al. (2000) showed that calves that were stressed due to both 
weaning and transfer to feedlots in Texas were more likely to be diagnosed with BRD 
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within of the first 14 days of arrival. Similarly, in another study calves that experienced 
marketing stress and weaning stress at transportation to feedlots had increased morbidity 
and number of treatments for disease which ultimately resulted in increased costs (Step et 
al., 2008).  This indicated that with increased stressors there were increased disease risks. 
 Not only does stress suppress the immune system, but performance and carcass 
traits were also negatively effected by temperature and social stress (Reinhardt et al., 
2009).  Step et al. (2008) showed that calves that experienced any type of preconditioning 
prior to feedlot exposure had increased carcass qualities. Specifically, yield grade was 
greater for preconditioned calves as compared to calves from the sale barn that 
experienced multiple stressors simultaneously. Therefore, calves that experienced high 
stress prior to feedlot arrival were less likely to become ill and during transition periods 
were under less stress and therefore were more likely to respond to the vaccine. 
Genetic Selection 
The ability to select for animals with a lower BRD incident rate would be 
economically advantageous. Selection for improved response to infectious agents 
associated with BRD may serve a similar purpose in improved animal health.  While 
selection for BRD incidence has been studied, it does not appear to be a promising 
selection method to minimize BRD prevalence.  In a 15-year study by Snowder et al. 
(2006), heritability estimates ranged from 0.04 to 0.08 for BRD incidence in the feedlot.  
In a second BRD incidence study, heritability for both pre-weaning and feedlot periods 
were evaluated.  Similarly, the trait appeared to be lowly heritable, with heritability 
estimates ranging from 0.03 to 0.11 (Schneider et al., 2010).  Current research suggested 
selection for BRD incidence will offer little or limited improvement.  Investigation for an 
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indicator trait, such as response to vaccination or increased activated T-cells for viral 
pathogen response, could offer more genetic progress if these immune characteristics 
were heritable or could be shown to have high correlations with decreased disease 
incidence. 
Disease resistance and immune response have been closely studied in other 
species, and have shown higher heritability estimates for immune response and specific 
disease resistance than selection for reduced BRD incidence exhibited.  In a study 
evaluating pig response to vaccination, a significant breed difference was seen between 
five represented breeds (Rothschild et al., 1984).  In porcine, the heritability of both 
immune response to vaccines and specific disease resistance have shown wide variation 
heritability estimates.  In an experiment for immune response to vaccination by 
Rothschild et al. (1984), there was high genetic variation between half and full sib 
relatives.  While half sibs appeared to have low heritability estimates, 0.10 h2, for 
immune response following vaccination, full sibs had moderately high heritability 
estimates, 0.42 (Rothschild et al., 1984).  From the paternal half-sibs low heritability 
estimates and the significance of dam in the model, there appeared to be large maternal 
influences on immune response in pigs.  There have been a number of experiments 
investigating disease resistance to atrophic rhinitis (AR); which suggests large variation 
in heritability estimates for resistance, similar to those for vaccine immune response.  
Heritabilities for disease resistance in swine have been reported from 0.12 to 0.42 (Elias 
and Hamori, 1976; Kennedy and Moxley, 1980). Due to this large variation, there may be 
increased opportunity for genetic improvement.  The major histocompatibility complex 
(MHC) has been known for its vital role in immune response.  For the immune response 
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to vaccine study, it appears as though there were genes in this region that influence an 
animal’s ability to respond to Bordetella bronchiseptica (Rothschild et al., 1984).  
Therefore, this region would be of high interest for investigation of cattle immune 
response genes as well.  
Conclusion 
 Animals must be healthy in order to reach their performance potential (Powell et 
al., 2010).  Management practices vary from operation to operation and were highly 
dependent on the region and environmental conditions under which operations were 
managed, size of cattle operation, past disease experiences, and possibility to introduce 
new pathogens.  Infectious pathogens were not identical across all herds, locations, or 
present in equal quantities throughout the year.  Thus, response to vaccination has been a 
challenge to measure and to date shows low to moderate heritability.  However, possible 
candidate genes for immune response show promise and await discovery.  
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Abstract 
 
Vaccination against viruses has been shown to help prevent bovine respiratory 
disease in cattle.  However, circulating passively-acquired maternal antibody level and 
calf age have been shown to impact the ability of a calf’s immune system to respond to 
vaccination.  The objectives of this study were to identify and evaluate sources of 
environmental and management factors that effect 1) passively acquired BVDV type 2 
antibody level, 2) rate of decline in passively-acquired BVDV type 2 antibody level, and 
3) response to BVDV type 2 vaccination.  A two-shot modified live vaccine was 
administered to 1,004 Angus calves that were weaned at either the initial vaccination 
(n=508) or the booster vaccination (n=469).  Bovine viral diarrhea virus type 2 antibodies 
were measured in serially collected serum samples in order to quantify antibody response 
to the vaccination.  Calf age nested within birth year season and dam age significantly 
(P<0.05) affected all traits evaluated.  The amount of circulating passively-acquired 
maternal antibodies present at the time of vaccination has a significant (P<0.05) effect on 
antibody response to vaccination for initial, booster, and overall response and final 
antibody level.  Calves that were weaned at the initial vaccination had significantly 
(P<0.05) higher final antibody levels and response to vaccination compared to animals 
weaned at the booster vaccination.  In order to mount an antibody response to 
vaccination, maternal antibodies in circulation need to be below a given threshold.  
However, the age at which a calf reached this threshold was dependent on dam age.  
Taken together these factors influence the age at which to initiate a vaccination protocol 
so as to successfully mount an antibody response to vaccination.   
Keywords: antibody response, vaccination, bovine, wean stress 
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Introduction 
 
 Passively acquired antibodies form the first line of defense against infectious 
pathogens for calves.  Colostrum quality and quantity can be highly variable among 
dams, therefore the amount of passively transferred maternal antibodies maybe highly 
variable from calf to calf even within the same herd (Menanteau-Horta et al., 1985).  
While maternal antibodies have been shown to be essential for early protection, they have 
been shown to block adaptive antibody response to vaccinations (Funnell, 2011).  Thus, 
at the time of vaccination it may be beneficial to have reduced maternal antibody levels 
in circulation.  However, once circulating maternal antibodies fall below a given point a 
calf may enter a period of disease vulnerability prior to vaccination (Funnell, 2011).   
Furthermore, variability in calf age can impact a calf’s ability to mount an immune 
response after vaccination (Endsley et al., 2003). 
 The protection provided by vaccination against viral and bacterial pathogens 
associated with bovine respiratory disease (BRD), such as bovine viral diarrhea virus, has 
been shown to be an effective management method to reduce BRD (Martin et al., 1999).  
Stress at the time of vaccination, such as weaning or transportation, has been shown to 
suppress the immune response, which can result in increased disease susceptibility and 
incidence rates (Niekamp et al., 2007; Salak-Johnson and McGlone, 2007).  The majority 
of BRD cases occur within 30 d post weaning and/or within the first 14 days upon feedlot 
arrival (Kirkpatrick et al., 2008).  Vaccination of calves prior to feedlot arrival, with 
minimal stress may increase antibody response to vaccination and help minimize BRD. 
 The objectives of this study were to identify factors that 1) influence passively-
acquired maternal antibody levels in circulation, 2) influence the decay rate of maternal 
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antibodies, and 3) evaluate the affect of environmental and management factors on 
antibody response to vaccination.   
Materials and Methods 
All animal procedures were approved by the Iowa State University Animal Care and Use 
committee. 
Animal Population 
Data and serum samples were collected on 1,004 head of purebred American 
Angus calves from the Iowa State University breeding project to evaluate passively 
acquired maternal antibody level and antibody response to bovine viral diarrhea virus 
type 2 (BVDV2) vaccination.  Calves were born in 2007, 2008, and 2009 and managed in 
two calving seasons, spring and fall.  There were 194 and 136 calves in 2007, 211 and 
139 calves in 2008, and 220 and 104 calves in 2009, born in the spring and fall seasons of 
each year, respectively.   
All calves, regardless of sex, were enrolled in the vaccination protocol 
(males=548 and females=456).  The 2009 fall born bull calves were castrated at birth 
(n=64), while all other male calves were kept intact for the duration of the vaccination-
wean stress protocol.   
Spring born calves ranged from 86 to 205 d of age when the initial vaccination 
was administered, with an average age of 148.8 d (S.D. 24.4).  Fall born calves ranged 
from 53 to 146 d of age at the time of initial vaccination, with an average age of 107.2 d 
(S.D. 19.6).  Calf weights at the time of initial vaccination ranged from 47.6 to 263.1 kg. 
Spring born calves averaged 163.3 kg (S.D. 36.7), fall born calves averaged 123.4 kg 
(S.D. 26.4) at initial vaccination.  
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Wean/Vaccination Protocol 
All calves in this study were vaccinated with Pfizer Bovishield Gold-5 
(Kalamazoo, MI).  This five-way vaccine contained modified live antigens against: 
infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV), 
parainfluenza-3 (IP3), and bovine viral diarrhea virus types 1 and 2 (BVDV1 and 
BVDV2).  The vaccine was administered using a two-shot protocol, an initial vaccination 
was given and then three weeks later (average = 21.1 d, S.D. = 2.1 d) a booster 
vaccination was administered.  Within each year-season, approximately half of the calves 
were weaned at initial vaccination (n=508) and the other half of the calves were weaned 
at booster vaccination (n=496) (Figure 1). Calves weaned at the initial vaccination 
averaged 138.6 d (S.D. 18.0) and calves weaned at the booster vaccination averaged 
127.6 d (S.D. 27.4) at initiation of the vaccination protocol. 
Sample Collection 
 To evaluate response to BVDV2 vaccination, BVDV2 antibody levels were 
measured in calf serum.  Briefly, ten milliliter jugular blood samples for measurement of 
antibody levels were collected during the vaccination protocol: 1) three weeks prior to the 
initiation of the vaccination protocol (pre-vaccination), minus three weeks (n=613); 2) 
just prior to initial vaccination (initial), week zero (n=1,004); 3) at booster vaccination 
(booster), week three; and 4) three weeks after booster vaccination (final), week six 
(Figure 1). Serum samples were collected approximately three weeks apart (average = 
21.9 d, S.D. 2.5).  After collection, whole blood was allowed to coagulate overnight at 
4°C.  Blood samples were brought to room temperature and centrifuged for 20 minutes at 
1800 x g for serum collection.  Serum was separated from red blood cells and was evenly 
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aliquoted into three 1.5 mL tubes and stored at -20°C until analyzed by virus 
neutralization.   
At each serum collection time point, calf weight (kg) was recorded.  Additionally, 
pinkeye scores for both right and left eyes (yes or no) were recorded at weaning (Kataria 
et al., 2011).  Birth weight was also collected on all calves. 
Virus Neutralization 
The amount of antibodies in serum samples that were able to neutralize cytopathic 
BVDV2 was determined by virus neutralization assays.  Briefly, 25 µL of calf serum was 
sequentially diluted 2-fold from 1:4 to 1:2,056 in 96 well microtiter plates to test for the 
amount of BVDV2 antibodies present.  Serum samples were evaluated in replicates of 
five within a single plate, along with a positive (cell) and negative (virus) control.  
Diluted serum samples were inoculated with cytopathic BVDV2 strain, Singer 296-C 
virus (obtained from the National Animal Disease Center USDA-ARS, Ames, IA), at 
1,000 viral particles per well.  Inoculated serum samples were incubated in 5% CO2 at 
37°C for an hour.  Fetal bovine turbinate cells were added to each well and cultured for 
seven days in 5% CO2 at 37°C in minimum essential medium with Earles salts, 2.5% 
Lactalbumin hydrolysate, 2.2% sodium bicarbonate, 0.7% L-Glutamine, 0.06% 
gentamicin, and 10% BVDV2 free, gamma radiated fetal bovine serum.   After seven 
days, cells were evaluated to determine the highest serum dilution that was capable of 
neutralizing cytopathic BVDV2.  Bovine viral diarrhea virus type 2 antibody levels were 
recorded as the log base two reciprocal of the highest serum dilution that blocked 
cytopathic BVDV2 and was averaged across the five sample replicates.  Serum that was 
unable to neutralize virus at a 1:4 dilution was recorded as an antibody level of zero.   
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Variable Calculation 
To evaluate factors that impact maternal antibody levels, two variables were 
evaluated: passively-acquired maternal BVDV2 antibody level and decay rate of 
passively-acquired maternal BVDV2 antibody.  Initial antibody level was a measure of 
passively-acquired maternal antibodies present in the circulatory system immediately 
prior to vaccination.  Additionally, to evaluate the decay of maternal antibodies the decay 
rate was defined as: .  Where the numerator was the 
difference between the initial antibody level (initial) and three weeks prior to vaccination 
(pre-vac).  The denominator was the difference between calf age at the initial serum 
collection (iage) and the age at the pre-vaccination serum collection (preage). 
To evaluate individual antibody response to BVDV2 vaccination, four variables 
were evaluated.  Booster antibody level was defined as the amount of BVDV2 antibodies 
that were present at the time of booster vaccination.  Final antibody level was a 
measurement of total antibody development of the animal three weeks post booster 
vaccination (end of the vaccination protocol).  Response to initial vaccination (initial 
response) was defined as the difference between the booster and initial antibody levels.  
Response to booster vaccination (booster response) was defined as the difference 
between final and booster antibody levels.  Overall response was defined as the 
difference between final and initial antibody levels (Figure 1). 
Additionally, animals were also categorized into three response levels based on an 
animal’s overall antibody response to BVDV2 vaccination.  Animals were grouped as 
non-responders if the overall response was zero or less (52% of population), low 
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responders if the overall response was between zero and five (25%), and high responders 
if the overall response was greater than five (23%). 
Statistical Analysis 
Environmental and management factors were evaluated for their effects on 
antibody levels at various time points and antibody response to BVDV2 vaccination 
using the MIXED procedure in SAS version 9.2 (SAS Institute, Cary, NC).  Means for 
calf age (d), antibody level (reciprocal base 2 log), and weight (kg) for the four collection 
times (pre-vaccination, initial, booster, and final) were reported in Table 1.  Additionally, 
means were evaluated by season to show season differences in management of the cattle 
and thus the reason for calf age nested within year season included in the models.   
Calves with titers of zero for all three collection points of initial, booster, and final 
antibody levels were removed from the data set before statistical analysis (n=8). 
To identify environmental and management fixed effects for pre-vaccination 
antibody level and initial antibody level the following model was used: 
 Yijklm = pre-vaccination antibody level or initial antibody level for calf m.  Where YSi = 
year and season classification (i=6 classes of 2007S, 2007F, 2008S, 2008F, 2009S, and 
2009F); DAj = dam age (j=two to 11 years old); and Sexk = calf sex (k=bull, heifer, and 
steer) were fit as class effects.  IDl = dam ID and was fit as a random effect to account for 
dams with multiple offspring in the study. Covariate effects of BWm = birth weight of 
calf m; Am(YSi) = calf age at pre-vaccination or initial collection time nested within year 
season classes and Am*Am(YSi)  = quadratic effect of calf age nested within year season 
classes.  The error term (eijklm) was assumed to be normally distributed with mean = 0 and 
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variance = !e2. Variables were sequentially removed from the model based on 
significance level of P>0.05, such that the final models included only statistically 
significant factors and the random dam ID effect. 
Fixed effects that impacted decay rate of maternal antibodies were evaluated 
using the following model:  
 
where yijklm = maternal antibody decline for calf m.  YSi = year and season classification 
(i=6 classes of 2007S, 2007F, 2008S, 2008F, 2009S, and 2009F); DAj = dam age (years; 
j=two to 11 years old); and Sexk = calf sex (k=bull, heifer, and steer) were fit as class 
effects.  IDl = dam ID of calf m fit as a random effect to account for dams with multiple 
offspring in the study. Covariate effects of Am(YSi) = calf age at pre-vaccination nested 
within year season classes and Tm = pre-vaccination antibody level of calf m. The error 
term (eijklm) was assumed to be normally distributed with mean = 0 and variance = !e2. 
Variables were sequentially removed from the model based on significance level of 
P>0.05, such that the final models only had statistically significant effects and random 
dam ID effect (Table 3). 
 To evaluate environmental and management effects on final antibody level (total 
antibody production at the end of the six week protocol), initial antibody response, 
booster antibody response, and overall antibody response the following model was used: 
 
where yijklmno = response variable (final antibody level, initial response, booster response, 
or overall response) measured on calf o.  Where effects of YSi = year and season 
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yijklm = µ +YSi +DAj + Sexk + IDl + Am (YSi) +Tm + eijklm
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yijklmno = µ +YSi + Sex j +WSk + PEl +DAm + IDn
+To +To *To + Ao(YSi) + Ao * Ao(YSi) + ADGo + eijklmno
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classification (i=6 classes of 2007S, 2007F, 2008S, 2008F, 2009S, and 2009F); Sexj = 
calf sex (j=bull, heifer, or steer); WSk = timing of wean stress (k=initial or booster); PEl = 
pinkeye classification at weaning (l=0 or 1); and DAm = dam age dam age (years, m = 
two to 11 years old) were fit as class effects. IDl = dam ID of calf m fit as a random effect 
to account for dams with multiple offspring in the study. Covariates of To = initial 
antibody level of calf o (for final antibody level, initial response, and overall response), 
or booster antibody level of calf o (for booster response); To*To  = quadratic effect of 
initial antibody level of calf o (for final antibody level, initial response, and overall 
response), quadratic effect of booster antibody level of calf o (for booster response); Ao 
(YSi) = calf age at vaccination (d, o=age at final collection for final antibody level, age at 
initial vaccination for initial response and overall response, and age at booster 
vaccination for booster response) nested within the year season classes; Ao*Ao(YSi)  = 
quadratic of calf age at vaccination was fit with the same age variables for the four 
response dependent variables as linear effect of calf age nested within year season 
classes; and ADGo = ADG for the three response periods tested (initial, booster, and  
overall responses; ADG was not fit in the final antibody level model) were fit.  The error 
term (eijklmo) was assumed to be normally distributed with mean = 0 and variance = !e2.  
Variables were sequentially removed from the model based on significance level of 
P>0.05, such that final models for final antibody level, initial response, booster response, 
and overall response only had statistically significant effects and dam ID random effect 
(Table 4). 
To evaluate age differences in animal responses to vaccination, animals were sub-
divided into response groups of non-, low, and high responders.  Then to identify factors 
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that effect age at initial vaccination and an estimated age to achieve either a non-, low, or 
high response, the following model was used: 
 
Where iageijklm = age at initial vaccination of calf m.  Effects of Ri = response group 
(i=non-, low, or high); WSj = timing of wean stress (j=initial or booster), DAk = dam age 
(years, k = two to 11 years old); and YSl = year and season classification (l=6 classes of 
2007S, 2007F, 2008S, 2008F, 2009S, and 2009F) were fit as a class variables.  The error 
term (eijkl) was assumed to be normally distributed with mean = 0 and variance = !e2.  
Variables were sequentially removed from the model based on significance level of 
P>0.05, such that the final model only had significantly statistically significant effects.  
Results and Discussion 
 
 Vaccines have been used as a tool to prevent disease, such as bovine respiratory 
disease, in many species and against numerous infectious agents.   However, in order to 
provide protection and prevent disease, a vaccine must elicit an immune response in 
animals.  While passively-acquired maternal antibodies serve as the first line of defense 
until a calf’s immune system has developed sufficiently to prevent illness, they can also 
inhibit a vaccines ability to stimulate the immune system.  For example, maternal 
antibodies can bind to the virus antigen and thereby prevent recognition by the adaptive 
immune system (Zimmerman et al., 2006).  Thus, it is important to strike a balance 
between having enough passively-acquired maternal antibodies to prevent disease, it is 
also important to have sufficiently low levels to allow the adaptive immune system to 
respond to the vaccine.  Therefore, it is important to understand the 
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environmental/management factors that impact the levels of passively-acquired maternal 
antibodies present in a calf’s circulation. 
The ability of an animal to respond to a vaccine has been shown to vary from 
animal to animal, some of this variation has been shown to be due to environmental and 
genetic factors (Rothschild et al., 1984).  Maternal antibody levels in circulation have 
been shown to decrease over time.  In addition, antibody levels appear to decrease at 
different rates depending on the antibody type (Menanteau-Horta et al., 1985).  For 
example, Menanteau-Horta et al. (1985) reported that BVDV antibodies decay more 
rapidly than infectious bovine rhinotraceitis antibodies.  Additionally, Kirkpatrick et al. 
(2001) reported that the amount of time that it took infectious bovine rhinotraceitis, 
BVDV1, BVDV2, parainfluenza-3, and bovine respiratory syncytial virus to decay to 
seronegative levels in calves varied between 65.1 and 200.2 days.  These reports indicate 
that protection against infectious pathogens was not consistent across pathogens, and 
therefore the duration of maternal protection to a specific pathogen will also vary from 
pathogen to pathogen. 
Pre-vaccination and initial antibody levels were evaluated as two, presumably 
highly correlated, measures of passively acquired maternal antibody levels.  Pre-
vaccination antibody and initial antibody levels were significantly influenced (P<0.0001) 
by dam age, birth weight, and calf age nested within year season (Table 2).  As dam age 
increased from two to six years of age, the observed level of passively-acquired maternal 
antibodies increased (P<0.05) (Figure 2). However, as dam age continued to increase 
there was no further increase in passively-acquired maternal antibody level (Figure 2).  
Similarly, as a calf’s birth weight increased, pre-vaccination and initial antibody levels 
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increased (P<0.0001); for every one kilogram increase in birth weight there was a 0.020 
(±0.0048) increase in pre-vaccination antibody levels and a 0.019 (±0.0036) increase in 
initial antibody level (data not shown). As calf age (year-season) increased, initial 
antibody level decreased (P<0.0001) at different rates across the different year seasons 
(Figure 3).  Similar results were observed when pre-vaccination and initial antibody 
levels are compared across dam ages (Figure 2).  Similar linear effects of age have been 
observed in a number of other studies (Kirkpatrick et al., 2008; Munoz-Zanzi et al., 2002; 
Thurmond et al., 2001).    
The rate of decline of maternal antibody level was significantly (P<0.0001) 
influenced by dam age, pre-vaccination antibody levels, and calf age nested within year 
season (Table 2).  Similar to pre-vaccination and initial antibody level, as calf age (year-
season) increased, the rate of decline in passively-acquired maternal antibody level 
decreased (Figure 4).  The significance (P<0.05) of pre-vaccination antibody level may 
indicate that maternal antibody decay rate was dependent on the amount of passively-
acquired maternal antibodies that were present (P<0.05).  As pre-vaccination antibody 
level increased by one titer unit, the rate of maternal antibody level decline decreased by 
0.0098 (±0.0012) titer units per day of age (data not shown). O’Neill et al. (2006) 
reported a similar finding, in that the decay rate of maternal antibodies from -28 d to day 
zero was dependent on the amount of pre-vaccination antibodies present at -28 d.  
Therefore, animals with higher levels of passively-acquired maternal antibodies will take 
longer to reach seronegative titers than animals with lower maternal antibody levels.  The 
rate of decline in passively-acquired maternal antibody level in calves from older dams 
was slower than that observed in calves from younger dams when year season, age of 
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dam, calf age, and pre-vaccination antibody levels were accounted for (Table 3). In 
contrast, there was no consistent trend of dam age on the absolute rate of maternal 
antibody decline (Table 3).   
A number of studies have shown that maternal antibodies can affect an animal’s 
ability to respond to vaccination (Funnell, 2011; Menanteau-Horta et al., 1985; Munoz-
Zanzi et al., 2002; Zimmerman et al., 2006). While maternal antibodies have been shown 
to be vitally important for disease reduction in calves with undeveloped immune systems, 
they have also been shown to block an animals’ ability to produce acquired antibodies in 
response to vaccination (Zimmerman et al., 2006).  Therefore, environmental and 
management factors were evaluated to quantify their impact on final antibody level, 
initial response, booster response and overall response.  Sex of calf, wean stress, pinkeye 
status, dam age, quadratic effect of initial antibody level, year-season, calf age nested 
within year season, quadratic effect of calf age within year-season, and or average daily 
gain influenced (P<0.05) final antibody level, initial response, booster response, and 
overall response (Table 4). The sex of the calf only affected (P<0.05) booster response 
and ADG only impacted (P<0.05) initial response.    Calves that were subjected to wean 
stress at initial vaccination had a more robust (P<0.01) antibody response then calves that 
were weaned at booster vaccination (Figure 5).    This agrees with the work reported by 
Duff and Galyean (2007) in that when pre-weaning vaccination was not possible, 
weaning at the initial vaccination offered the greatest response to vaccination. 
Interestingly, calves that experienced a bout of pinkeye did not have as robust of an 
overall response (P<0.05) and subsequently, they did not have has high of a final 
antibody titer (p<0.05) as calves that did not have pinkeye (Table 4).  This result may 
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indicate that calves that suffer from pinkeye may have a decreased ability to respond to 
an immune challenge compared to uninfected calves.  In addition, calves that had a 
higher ADG during the initial response period had an increased (P<0.05) initial response 
to the vaccination (Table 4).  For every one kg/d increase in ADG, initial antibody 
response increased by 0.068 (±0.033) titer units (data not shown). 
There was a linear effect of calf age nested within year season classes on initial 
and overall response, while there was a quadratic effect of age nested within year season 
on booster response (Table 4, Figure 6).  With the exception of calves born in the fall of 
2008, initial response to vaccination decreased as calf age increased (Figure 6a). In 
contrast, with the exception of the calves born in the fall 2007, booster response to 
vaccination increased as calf age increased (Figure 6b).   Similarly, with the exception of 
calves born in the fall of 2007 and the spring of 2008, overall response to vaccination and 
final antibody titer increased as calf age increased (Figure 6c and 6d).   
Maternal antibody levels present in the circulation at the time of vaccination 
(initial or antibodies at the booster vaccination) significantly (P<0.0001) influenced final 
antibody level, initial response, booster response and overall response (Table 4). 
Circulating passively-acquired maternal antibodies had a quadratic effect (P<0.05) on 
final antibody level, initial response, booster response and overall response (Table 4; 
Figure 7).  These results indicate that initial antibody level does not have a consistent 
affect on final antibody level or antibody response to vaccination.  Calves with the lowest 
initial antibody levels had increased initial and overall responses to BVDV2 vaccination 
(Figure 7a and 7c).  Only those calves that had an initial antibody titer <2 exhibited a 
positive initial response (Figure 7a), while calves with an initial antibody titer <3.12 
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exhibited a positive overall response (Figure 7c). These results appear to indicate that 
there is a minimal threshold that passively-acquired maternal antibodies need to fall 
below before a calf can mount an antibody response to BVDV2 vaccination.  Above this 
threshold level, it would appear that calves do not seroconvert. This finding was similar 
to that reported by Munoz-Zani et al., (2002), where animals that had maternal antibody 
titers < 4 were able to develop an antibody response.  Similarly, there was a quadratic 
effect (P<0.001) of booster antibody level on booster response (Table 4; Figure 7b).  
Calves with the lowest booster antibody levels had increased booster response to BVDV2 
vaccination (Figure 7b).  Interestingly, calves that had a booster antibody level <5 
exhibited a positive booster response, which indicates that even in the presence of higher 
antibody levels than those seen at initial vaccination, the immune system of calves could 
still respond to vaccination.     
Due to the quadratic effect of initial antibody level on final antibody level, 
animals with very low or very high initial antibody levels have high final antibody levels 
(Figure 7d).  This result may arise by two different means.  First, in calves with low 
initial maternal antibody levels, the immune system can mount a robust antibody 
response to vaccination as maternal antibody levels have dropped below a given 
threshold below which passively-acquired maternal antibodies cannot block the 
vaccination antigen, thereby allowing the immune system to respond to the vaccine.  
Ultimately, at end of the vaccination protocol, these calves have high levels of BVDV2 
antibodies due to a robust acquired antibody immune response to the vaccine.  In 
contrast, in calves with high initial antibody levels, the immune system cannot mount a 
response to vaccination as the immunogen is blocked from the immune system due to the 
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high levels of passively-acquired maternal antibodies. However, these maternal 
antibodies do not significantly degrade over this time period.  Thus, at end of the 
vaccination protocol, a calf has high levels of BVDV2 antibodies even though the calf 
has not seroconverted.  It is important to note that in this study antibody levels were 
simply a measure of the total amount of neutralizing BVDV2 antibodies present in the 
serum at a given time, as the assay employed in this study could not differentiate between 
passive and acquired antibodies.   
 In order to estimate the age at which a calf might be able to mount a BVDV2 
antibody response to vaccination, animals were divided into three overall response levels 
(non, low, and high).  After the significant effects (P<0.05) of year season, response 
level, and wean stress were accounted for, high-response (antibody response level > 5) 
calves were on average 136 d (±1.2 d) old at initial vaccination.  Low-response (antibody 
response level > 0 but < 5) calves were on average 130 d (±1.0 d) old at initial 
vaccination.  While, non-responder (antibody response level =< 0) calves were on 
average 124 d (±0.07) of age. These ages were higher than the ages reported by Munoz-
Zani et al. (2002) for seroconversion.  However, they were younger than those reported 
by Menanteau-Horta et al. (1985), in which calves responded well to a BVDV and IBR 
vaccine when the vaccine was administered at 196 d of age or after, once the passive 
antibodies had disappeared.  However, in a study by Munoz-Zanzi et al. (2002), dairy 
calves were BVDV2 seronegative (titer # 4) by 114 days of age.  The variation in these 
studies illustrates the challenges one needs to consider when designing a single 
vaccination protocol.  The ages for low and high-responders indicate that vaccination of 
calves at an older age, when fewer maternal antibodies were in circulation, elicited an 
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increased overall antibody response. Additionally, as shown by Fulton et al. (2004) 
passive antibodies in circulation were capable of binding to vaccine antigens and thus 
preventing an acquired antibody response.  
Conclusions 
Calves from younger dams have lower circulating passively-acquired maternal 
antibodies than calves from older dams.   In addition, as calves get older, the level of 
circulating maternal antibodies decreased. With these two concepts in mind, it should be 
recognized that calves from younger dams would be susceptible to a BVDV2 infection at 
an earlier age because maternal antibodies have disappeared.  Furthermore, antibody 
response to vaccination was dependent upon when wean stress and vaccination occur, 
relative to one another, the level of circulating maternal antibodies and the age of the calf 
within year season.  Taken together these factors will impact the optimal time in which to 
vaccinate calves. 
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Table 1.  Means for titer level, calf age, and calf weight at four serum collection time 
points and maternal decay, samples were collected ~21 days apart.  Data are also reported 
by calving season, spring or fall. 
 
a  The rate that passively-acquired maternal antibodies disappear from circulation.    
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Table 2. Significant (P<0.05) factors for fixed sources of variation from the MIXED 
model analysis for Pre-vaccination Antibody Level and Initial Antibody Level 
…  P>0.05  
NA = not applicable, NT = not tested. 
 
 Pre-
vaccination 
Antibody 
Level 
 
Initial 
Antibody 
Level 
 
Rate of Decline 
of Maternal 
Antibody Level 
Rate of Decline 
of Absolute 
Maternal 
Antibody level 
Year-season … … … … 
Dam Age <0.0001 <0.0001 <0.0001 <0.03 
Sex … … … … 
Birth Weight <0.0001 <0.0001 NT NT 
Age(year-season) <0.0001 <0.0001 <0.0001 <0.0001 
Pre-Vaccination 
Antibody titer 
NA NA <0.0001 <0.0001 
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Table 3.  LSMean for rate of decline (titer unit/day) of maternal antibodies by age of dam 
and titers converted into antibody number decline.  Estimates with different superscript 
(a,b,c,d) are significantly different at P<0.05. 
 
 
 
 
 
 
 
a Titer decline rate converted to absolute antibody decline (2 raised to the power of the 
titer log score in the table in column “Titer Decline Rate”). 
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Table 4. Significant (P<0.05) factors for fixed sources of variation from the MIXED 
model analysis for Final Antibody Level, Initial Response, Booster Response, and 
Overall Response  
 
 
…  P>0.05  
*** Variable not tested in that response model 
Blank cells: linear effects of quadratic cells that were significant P<0.05, therefore 
the linear effect was not reported 
 Final  
Antibody 
Level 
 
Initial 
Response 
 
Booster 
Response 
 
Overall 
Response 
Sex … … 0.0393 … 
Wean stress 0.0116 <0.0001 … 0.0078 
Pinkeye  0.0364 … … 0.0360 
Dam Age 0.0002 0.0043 <0.0001 0.0002 
Titer     
Titer*Titer <0.0001 <0.001 0.0035 <0.0001 
Year-season … 0.0163 … ... 
Age(year-season) <0.0001 <0.0001  <0.0001 
Age*Age(Year-season) … … 0.0042 … 
ADG *** 0.0404 … … 
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Figure 1.  Diagram of serum sample collection, vaccination timing, and weaning timing.  
The black outlined arrows at week 0 and 3 indicate time when vaccine was administered 
to calves.  The collection tubes indicate the three serum collection time points. 1) Pre-
vaccination antibody level (n=613) 2) Antibody level at initiation of the vaccination 
protocol (n=1,004).  3) Antibody level in calves 3 weeks after the initial vaccination 
(n=1,004), i.e. response to initial vaccination and at booster.  4) Final antibody level 
achieved following the 2-shot protocol (n=1,004).  The first arrow indicates that half 
(n=508) of the calves were weaned at initial vaccination.  The second arrow indicates the 
time of weaning for the second half (n=496) of the calves.  The arrows indicate the 
evaluated variables, a) pre-vaccination antibody level (-3 weeks), b) initial antibody level 
(week 0), c) final antibody level (6 weeks), d) response to initial vaccination (week 3 – 
!
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week 0), e) response to booster vaccination (week 6 – week 3), and f) overall response 
(week 6 – week 0). 
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Figure 2. LSMean antibody titers for dam age antibody transfer at pre-vaccination serum 
collection and initial serum collection.  Significant (P<0.05) differences are designated by 
letters. 
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Figure 3.   Calf age differences are presented within the six year-season classes for Initial 
Antibody Level (base 2 log) with assumptions of: intercept = 5.9604; dam age (5) = -
0.6476; birth weight = 38.1 kg*0.0186. 
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Figure 4.  Calf age differences within year-season classes for rate of maternal antibody 
decline (titer/day) with assumptions: intercept = 0.05336; dam age (5) = -0.02439; pre-
vaccination antibody level = 4.37*-0.0098. 
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Figure 5. LSMean titer scores for the two wean stress periods for initial response and 
overall response.  Animals weaned at initial vaccination elicit a greater response to 
vaccination than animals.  Different letters represent significant differences within each 
response variable at P<0.05. 
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Figure 6. Calf age (d) differences are presented within the six year-season classes for a) 
Initial Response (Assumptions: intercept = 1.2767; dam age (5) = 0.5396; initial titer 
level = 3.1(linear = -0.8479; quadratic = 0.06134); ADG = 1.1 kg/day*0.06776; 
individual year season estimates were included for each year- season (2007S = 0.01334; 
2007F = 2.0403; 2008S = 1.5900; 2008F = -0.8277; 2009S = 0; 2009F = 0.8472); at 
initial wean stress (0)), b) Booster Response (Assumptions: intercept = 4.3966; dam age 
(5) = -0.01084; booster titer level = 2.6 (linear = -0.9358; quadratic = 0.03547); at initial 
wean stress (0); for steers (0)), c) Overall Response (Assumptions: intercept = 5.0099; 
dam age (5) = 0.1755; initial titer level = 3.1 (linear = -1.9485; quadratic = 0.1102); at 
initial wean stress (0); with pinkeye (0)), and d) Final Antibody Level (Assumptions: 
intercept = 4.8118; dam age (5) = 0.1751; initial titer level = 3.1 (linear = -0.9493; 
quadratic = 0.1107); at initial wean stress (0); with pinkeye (0). 
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Figure 7. a) Initial antibody quadratic effect on initial response (Assumptions: intercept 
= 1.2767; dam age (5) = 0.5396; initial titer level: linear = -0.8479; quadratic = 0.06134; 
ADG = 1.1 kg/day*0.06776; individual year season estimates were included for each 
year- season (2007S = 0.01334; 2007F = 2.0403; 2008S = 1.5900; 2008F = -0.8277; 
2009S = 0; 2009F = 0.8472); calf age nested in year season where average age at initial 
vaccination = 133.0 d (2007S = -0.00234; 2007F = -0.02100; 2008S = -0.01729; 2008F = 
0.005788; 2009S = -0.00435; 2009F = -0.01126); at initial wean stress (0)); b) booster 
antibody level quadratic effect on booster response (Assumptions: intercept = 4.3966; 
dam age (5) = -0.01084; booster titer level: linear = -0.9358; quadratic = 0.03547; calf 
age nested in year season where average age at booster vaccination = 154.1 d (linear: 
quadratic; 2007S = -0.01902: 0.000110; 2007F = -0.02013: 0.000054; 2008S = -0.03276: 
0.000135; 2008F = -0.03488: 0.000175; 2009S = -0.04737: 0.000261; 2009F = -0.03624: 
0.000187); at initial wean stress (0); for steers (0)); c) initial antibody level quadratic 
effect on overall response (Assumptions: intercept = 5.0099; dam age (5) = 0.1755; initial 
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titer level: linear = -1.9485; quadratic = 0.1102; calf age nested within year season where 
average age at initial vaccination = 133.0 d (2007S = 0.005185; 2007F = -0.00304; 2008S 
= -0.00359; 2008F = 0.001048; 2009S = 0.004308; 2009F = 0.001716); at initial wean 
stress (0); with pinkeye (0)); d) initial antibody level quadratic effect on final antibody 
titer (Assumptions: intercept = 4.8118; dam age (5) = 0.1751; initial titer level: linear = -
0.9493; quadratic = 0.1107; calf age nested within year season where average calf age at 
final antibody level = 176.1 d (2007S = 0.004994; 2007F = -0.00110; 2008S = -0.00172; 
2008F = 0.001903; 2009S = 0.004311; 2009F = 0.002451) at initial wean stress (0); with 
pinkeye (0)). 
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Abstract 
 
 The objective of this study was to evaluate the effects of response to vaccination 
and vaccination-weaning management on performance and carcass quality traits in beef 
cattle.  Response to bovine viral diarrhea virus type 2 (BVDV2) was evaluated as the 
amount of BVDV2 specific antibodies produced in response to BVDV2 vaccination.  
Effects of management-induced stress from weaning calves at either the initial or booster 
vaccination were assessed. Calves were followed throughout the feedlot phase, with 
yearling ultrasound (n=957), pre-harvest (n=762), and carcass data being collected on 
harvested animals (n=673).  In this study, 48% of the animals were observed to have 
positively responded to the vaccine, with a higher final antibody level than initial 
vaccination antibody level.  Increased final antibody level significantly (P<0.05) 
increased yearling weight and subcutaneous fat over the rump. The interaction between 
final antibody level and wean stress treatment had a significant (P<0.05) effect on 
Warner-Bratzler shear force (WBSF) and pH.  While, overall antibody response by wean 
stress interaction had a significant (P<0.05) effect on ADG and pH.  Animals weaned at 
initial vaccination had significantly (P<0.05) higher intramuscular fat and harvest weights 
than animals weaned at the booster vaccination, with no significant (P<0.05) effects from 
final antibody level or overall response.  Animals that were weaned at the initial 
vaccination with high response level had significantly (P<0.05) higher ADG, harvest 
height, and HCW compared to animals with a high response level weaned at the booster 
vaccination.  Increased antibody response did not significantly (P<0.05) decrease 
performance or carcass quality in finished cattle.  Therefore, increased antibody response 
does not appear to have detrimental effects on performance or carcass quality traits. 
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Introduction 
 
Bovine respiratory disease (BRD) is among the most detrimental diseases that 
affect feedlot cattle today.  It has been observed to cause 75% of the morbidity and 
account for up to 50% of the mortality in feedlots (Gardner et al., 1999).  Annual costs of 
$750 million have been associated with BRD once treatment costs, increased labor, 
reduced performance and carcass losses were accounted for (Griffin, 1997; Holland et al., 
2010).  When compared to losses from treatment costs, a significantly higher portion of 
the economic loss was attributed to decreased carcass traits and reduced quality grade 
(Gardner et al., 1999).  BRD has been shown to have negative effects on performance and 
carcass traits including: ADG, BW, HCW, yield grade, LM area, and marbling score 
(Gardner et al., 1999; Holland et al., 2010; Schneider et al., 2010).  The high prevalence 
of BRD has lead to the development of preventative methods such as vaccination or 
metaphylaxis to reduce susceptibility, particularly during periods of high stress such as 
weaning and feedlot transition (Schneider et al., 2009).  However, it has been proposed 
that activation of the immune system may adversely affect growth and performance of 
animals (Spurlock, 1997). Therefore, effective BRD prevention programs that do not 
negatively affect performance or carcass qualities could reduce economic and 
performance losses from BRD. 
The aim of this study was to evaluate stress timing and antibody response to 
vaccination on growth and carcass composition traits by: 1) estimating the effects of 
antibody response to vaccination on yearling ultrasound traits, performance traits, and 
carcass quality traits; and 2) estimating the effect of weaning-vaccination management on 
yearling ultrasound traits, performance traits, and carcass quality traits.  We hypothesized 
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that animals which fail to initiate a BVDV2 antibody response to vaccination will have 
reduced performance and meat quality whereas, weaning-vaccination management would 
not affect performance or carcass quality traits. 
 
Materials and Methods 
 
All procedures were approved by the Iowa State University Animal Care and Use 
committee. 
Animal Population 
Data and serum samples were collected on 1,004 head of purebred American 
Angus calves from the Iowa State University breeding project to evaluate passively 
acquired maternal antibody level and antibody response to bovine viral diarrhea virus 
type 2 (BVDV2) vaccination.  Calves were born in 2007, 2008, and 2009 and managed in 
two calving seasons, spring and fall.  There were 194 and 136 calves in 2007, 211 and 
139 calves in 2008, and 220 and 104 calves in 2009, born in the spring and fall seasons of 
each year, respectively.   
All calves, regardless of sex, were enrolled in the vaccination protocol 
(males=548 and females=456).  The 2009 fall born bull calves were castrated at birth 
(n=64), while all other male calves were kept intact for the duration of the vaccination-
wean stress protocol with approximately half of the males within each year-season being 
castrated upon entry into the feedlot after the vaccination protocol.   
Spring born calves ranged from 86 to 205 d of age when the initial vaccination 
was administered, with an average age of 148.8 d (S.D.=24.5 d).  Fall born calves ranged 
from 53 to 146 d of age at the time of initial vaccination, with an average age of 107.2 d 
(S.D.=19.5 d).  Calf weights at the time of initial vaccination ranged from 47.6 to 263.1 
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kg. While spring born calves averaged 163.0 kg (S.D.=36.7 kg), fall born calves averaged 
123.3 kg (S.D.=26.4 kg) at initial vaccination.  
Weaning/Vaccination Protocol 
All calves in this study were vaccinated with Pfizer Bovishield Gold-5® 
(Kalamazoo, MI). This five-way vaccine contained modified live antigens against the 
following viral pathogens: infectious bovine rhinotracheitis (IBR), bovine respiratory 
syncytial virus (BRSV), parainfluenza-3 (IP3), and bovine viral diarrhea virus types 1 and 
2 (BVDV1 and BVDV2).  The vaccine was administered using a two-shot protocol, an 
initial vaccination was given and then followed three weeks later (average days=21.1, 
S.D. 2.1) by a booster vaccination. Within each year-season, approximately half of the 
calves were weaned at initial vaccination (I) (n=508) and the other half of the calves were 
weaned at booster vaccination (B) (n=496) (Figure 1).  Calves weaned at the initial 
vaccination averaged 138.6 d (S.D.=18.0) at initial vaccination and calves weaned at the 
booster vaccination averaged 127.6 d (S.D.=27.4) at the initial vaccination. 
Serum Sample Collection 
 To evaluate response to BVDV2 vaccination, BVDV2 antibody levels were 
measured in calf serum (Downey et al., submitted).  Briefly, ten milliliter jugular blood 
samples for measuring antibody levels were collected three times during the vaccination 
protocol: 1) just prior to initial vaccination (initial), week zero; 2) at booster vaccination 
(booster), week three; and 3) three weeks after booster vaccination (final), week six 
(Figure 1).  After collection, whole blood was stored at 4°C overnight.  Blood samples 
were centrifuged for 20 minutes at 1800 x g for serum separation and stored at -20°C. 
!!
*"!
At each serum collection time point, calf weight (kg) was recorded. Additionally, 
pinkeye scores for both right and left eyes (0 to 4 scale) were recorded at weaning.  
Pinkeye scores were then translated into categorical measures of yes or no, if pinkeye 
was present in either eye at weaning (Kataria et al., 2011).  
Virus Neutralization 
The amount of antibodies in serum samples that were able to neutralize cytopathic 
BVDV2 was determined by virus neutralization assays.  Briefly, 25 µL of calf serum was 
serial diluted 2-fold from 1:4 to 1:2,056 in 96 well microtiter plates to test for the amount 
of BVDV2 antibody levels present.  Diluted serum samples were inoculated with 
cytopathic BVDV2, Singer 296-C (obtained from the National Animal Disease Center 
USDA-ARS, Ames, IA) and incubated for seven days.  BVDV2 antibody levels were 
determined by the highest serum dilution that blocked cytopathic BVDV2 and were 
recorded as the log base two reciprocal of the dilution (Downey et al., submitted). 
Vaccination Response Variable Calculation 
Three measures of an individual animal’s response to BVDV2 vaccination were 
evaluated: 1) Final antibody level defined as the total amount of antibodies present three 
weeks post booster vaccination (end of the vaccination protocol); 2) overall antibody 
response which was calculated as final antibody level – initial antibody level; and 3) 
response level, where calves were categorized into three groups based on the level of 
overall antibody response.  Calves were classified as non-responders if the overall 
antibody response was zero or less (52% of population), low responders if the overall 
antibody response was between zero and five (25% of population), and high responders if 
the overall antibody response was greater than five (23% of population). 
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 Post Weaning Animal Management 
Post weaning management of calves varied slightly from year to year, and season 
to season.  Once calves finished the six-week vaccination-weaning protocol, all male 
calves were shipped to an off-site Iowa State University feedlot.  Approximately half of 
the males were kept intact and developed as potential replacement herd bulls while the 
castrated males were finished for marketing.  Bulls that were selected as potential 
replacements were selected primarily on ultrasound intramuscular fat percent or marbling 
EPDs.  All heifers were developed as potential female replacements at McNay Research 
and Demonstration Farm in Chariton, Iowa, through yearling performance and ultrasound 
measure collection. After yearling performance measures were collected, replacement 
heifers were selected and maintained at the cow/calf unit as breeding stock.  Selected 
heifers to be kept in the breeding project were selected on ultrasound intramuscular 
measurements, docility, genetic diversity, and vision (pinkeye presence or vision affects 
from pinkeye).  Whereas, unselected heifers were sent to an off-site Iowa State 
University feedlot for finishing.  Thus, the total number of heifers with carcass data was 
reduced due to replacement female selection.   
Yearling Ultrasound Collection 
Ultrasound body composition traits were collected on all calves at yearling age 
(n=957).  Ultrasound images were collected by an Ultrasound Guidelines Council 
certified field technician using a Classic Scanner 200 with an ASP-18 transducer (Classic 
Medical, Tequesta, FL). Ultrasound images were digitized and stored using a BlackBox 
Image Capturing System (Biotronics, Inc., Ames, IA). Ultrasound Guidelines Council 
certified laboratory technicians later interpreted images and submitted the data to the 
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American Angus Association and data was returned to Iowa State University. The 
following body composition traits were measured: 1) live weight (calves were held off 
feed until after data collection) (YWT); 2) subcutaneous fat thickness over the 
termination point of the biceps femoris in the rump (URFAT); 3) subcutaneous fat 
thickness at $ the lateral distance across the LM between the 12th and 13th ribs (UFAT); 
4) LM area between the 12th and 13th ribs (UREA); and 5) percent intramuscular fat 
(i.m. fat) within the LM between the 12th and 13th ribs (UPFAT). Docility (6 point 
scale, BIF, 2010) was also evaluated at the time yearling ultrasound measures were 
collected. 
Performance Traits 
Pre-harvest performance data was collected on all harvested animals within 7 d 
prior to harvest (n=762; includes selected bulls).  This included: weight (kg) and docility 
(6 point scale, BIF, 2010).  Pre-harvest traits analyzed included: 1) live weight of the 
animal (calves were held off feed until after data collection) (HWT) and 2) ADG from 
weaning to harvest (HWT- weaning weight/ harvest age – weaning age; kg/day). 
Carcass Quality Traits 
 Cattle were harvested (n=673) in a commercial facility according to standard 
industry protocol, and routine carcass measurements were collected by experienced 
individuals at approximately 24 h postmortem, including: 1) hot carcass weight (HCW), 
2) subcutaneous fat thickness at $ the lateral distance across the LM between the 12th 
and 13th ribs (CFAT), 3) LM area using plastic dot grid overlay between the 12th and 
13th ribs (CREA), 4) estimated percent kidney, pelvic, and heart fat (CKPH), and 5) 
USDA marbling score (MARB) to the nearest 10 marbling score units, (3.00 = Traces00; 
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4.00 = Slight00; 5.00 = Small00; 6.00 = Modest00; 7.00 = Moderate00; 8.00 = Slightly 
Abundant00; and 9.00 = Moderately Abundant00).  Fat thickness over the 12th rib was 
only adjusted if there was an obvious disruption of the fat thickness at the location of 
measurement, but overall fat distribution of the carcass was not used as adjustment 
criteria for fat thickness over the 12th rib.  Yield grade (YG) was calculated from these 
carcass measurements as follows: YG = 2.5 + (0.984 % CFAT, cm) + (0.2 % CKPH, %) + 
(0.0084 % HCW, kg) - (0.05 % CREA, cm2).  Animals were harvested as a single group 
for each year, season, and yearling sex group combination and therefore, harvest date was 
not included in subsequent analyses.  Approximately 48 h after harvest ultimate pH was 
measured on a sample of longissimus dorsi near the 12-13th rib interface (n=667). 
Warner-Bratzler Shear Force 
 A 2.54 cm thick steak was prepared for Warner-Bratzler shear force (WBSF) 
(n=592) evaluation.  All steaks were vacuum packaged, aged for 14 d from the harvest 
date at 2°C, and then frozen at -20°C until subsequent analysis.  At a later date, the frozen 
steaks were allowed to thaw at 4ºC for 24 h prior to cooking.  Steaks were broiled to an 
internal temperature of 71.1ºC.  After cooking, steaks were cooled at room temperature 
for at least four hours.  Six cores, 1.27 cm in diameter, were removed perpendicular to the 
surface of the steak and sheared once, using a Warner-Bratzler head attached to a TA-
XT2i Texture Analyzer (Texture Technologies Corp., Searsdale, New York). The 
Warner-Bratzler shear attachment crosshead moved at a speed of 200 mm/min. Peak 
force (kg) to shear each core was recorded using Texture Analysis Exponent Software 
(version 5.0.8.0, Texture Technologies Corp., Searsdale, New York). Mean peak force 
(kg) of the six cores was the trait analyzed for each sample. 
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Statistical Analysis 
To evaluate the effects of antibody response to vaccination on yearling 
ultrasound, performance, and carcass quality traits, statistical analyses were performed 
using GLM procedure in SAS version 9.2 (SAS Institute, Cary, NC).  The effects of 
vaccination response on yearling ultrasound traits of: YWT, URFAT, UFAT, UREA, and 
UPFAT were evaluated.  Performance traits analyzed were HWT and ADG from 
weaning to harvest.  Carcass traits evaluated were: HCW, CFAT, CREA, CKPH, MARB, 
YG, pH, and WBSF. 
Response to BVDV2 vaccination, wean stress treatment (wean stress), and the 
interaction between response to vaccination trait and wean stress management were 
evaluated on yearling ultrasound, performance, and carcass composition traits.  Response 
to BVDV2 vaccination was evaluated using the three defined traits independently: 1) 
final antibody level, fit as continuous covariate 2) overall antibody response, fit as 
continuous covariate, and 3) response level, fit as a categorical trait.  The following 
general model was used for all traits within each of the 3 vaccination response trait 
analyses: 
 
where  yijklmnop = ultrasound, performance, or carcass quality trait measured on calf p; Ri = 
antibody response variable, 1) final antibody level fit as a covariate; 2) overall response 
fit as a covariate; or 3) response levels (non, low, or high) fit as a class effect; WSj = 
wean stress treatment, (j = I or B);  Ri*WSj = antibody response variable (final titer, 
overall response, or response level) by wean stress interaction.  CGk = post-weaning 
! 
! 
yijklmnop = µ + Ri +WS j + Ri +WS j +CGk
+DAl + PEm +Docn + Ap (Sexo) + eijklmnop
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management contemporary group (year, season, gender, and management group) (k=1 to 
21 groups) fit as a class effect; DAl = dam age (years, l = 2 to 11 years old) fit as a class 
effect; PEm = pinkeye classification at weaning (m = 0 or 1) fit as a class effect; Docn = 
docility score (n = 1 to 6) fit as a class effect (for yearling ultrasound traits, docility score 
at yearling scanning was used; for performance and carcass traits, pre-harvest docility 
score was used).   Ap(Sexo) = covariate effect of calf age (yearling age for yearling 
ultrasound traits; pre-harvest age for ADG and HWT; and age at harvest for carcass 
traits) nested within yearling sex (Sexo = bulls, steers, or heifers).  The error term (eijklmop) 
is assumed to be normally distributed with mean = 0 and variance = !e2.  Variables were 
sequentially removed based on non-significance (P>0.05) from the model for each trait 
evaluated within each vaccine response trait analysis.   
Results and Discussion 
Animals in this study were managed to typical US beef industry endpoints.  Table 
1 presents means and standard deviations for age and traits by sex, which indicates the 
variability in growth and age at endpoint by sex.  Significant effects for yearling 
ultrasound, performance, and carcass quality traits have been presented for the final 
antibody level, overall antibody response, and response level analyses in Tables 2, 3, and 
4, respectively. 
The contemporary group the animals were managed within significantly (P<0.01) 
affected all yearling ultrasound, performance, and carcass quality traits (Tables 2, 3, and 
4).  The contemporary group effect was highly variable across the 21 management 
groups, with similar effects seen within ultrasound, performance, and carcass quality 
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traits and across antibody response models (final antibody level, overall response, and 
response level) (data not shown). 
Response to vaccination traits effects on yearling ultrasound measures 
The interaction between antibody response variables (final antibody level, overall 
antibody response, or response level) and wean stress treatment had no significant 
(P>0.05) effect on any yearling ultrasound traits (Tables 2, 3, and 4).  
Final antibody level had a significant (P<0.05) effect on YWT (Table 2). YWT 
increased as final antibody levels increased, e.g., for every one-unit increase in final 
antibody level YWT increased by 1.65 kg (±0.72 kg). However, neither overall response 
nor response level (non, low, and high) significantly (P>0.05) affected YWT.  
Additionally, YWT was significantly (P<0.05) affected by calf age nested within calf sex, 
dam age, and pinkeye presence in final antibody level, overall response, and response 
level analyses (Tables 2, 3, and 4).  Consistent with the work of Funk et al. (in 
preparation) our LSmeans for YWT based on at weaning pinkeye incidence found that 
calves without pinkeye had significantly (P<0.05) increased YWT compared to calves 
with pinkeye presence at weaning (data not shown). 
Final antibody level had a significant (P<0.05) effect on URFAT (Table 2). 
Animals with greater final antibody levels had increased URFAT, e.g., for every one-unit 
increase in antibody level URFAT increased by 0.008 cm (±0.003 cm).  Additionally, 
response level had a significant (P<0.05) effect on URFAT (Table 4).  Low and non-
response groups were significantly (P<0.05) different from each other (Figure 2): low 
responders had more URFAT (0.64 ±0.038 cm) while non-responders had the lowest 
URFAT (0.58 ± 0.037 cm).  Beyond the response to vaccination traits, URFAT was 
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significantly (P<0.05) affected by calf age nested within sex, dam age, and pinkeye 
presence at weaning for all three analysis models. 
Response to vaccination traits effects on performance traits 
Neither final antibody level nor it’s interaction with wean stress timing had a 
significant effect (P>0.05) on performance traits (Table 2).  This result indicates that 
increased antibody levels after vaccination neither favor nor compromise growth. 
However, the interaction between overall antibody response and wean stress 
significantly (P<0.05) influenced ADG (Table 3).  The ADG of animals that were 
weaned at the initial vaccination increased 0.00515 kg/d (±0.00227 kg/d) for every one-
unit increase in overall antibody response, compared to calves that were weaned at the 
booster vaccination that had a decrease in ADG of 0.00041 kg/d (±0.01422 kg/d) for 
every one unit increase in overall antibody response.  It is important to note that response 
to vaccination and subsequently response level are themselves complex traits influenced 
by factors such as antibody level at time of vaccination, calf age, and dam age (Downey 
et al., submitted). 
Furthermore, the interaction between response level (non, low, and high) and 
wean stress had a significant (P<0.05) effects on both ADG and HWT (Table 4, Figure 
3, and Figure 4).  Calves that had a high antibody response level and were weaned at 
initial vaccination gained significantly (P<0.05) faster than all non-responder calves, low 
responders weaned at initial vaccination, and high responders weaned at booster 
vaccination (Figure 3).  However, high responder calves weaned at initial vaccination 
were not significantly different (P>0.05) from low responder calves weaned at booster 
vaccination.  While an interaction between response classification group and timing of 
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wean stress exists for ADG, the fact that the non-responders were consistently the slowest 
gaining cattle is inconsistent with the work of Spurlock (1997) that development of an 
immune response detracts from growth performance.  
When looking at HWT in this study, all animals weaned at initial vaccination had 
the heaviest HWT (Figure 4).  Interestingly, while animals that were high responders and 
weaned at initial vaccination had the heaviest HWT, high responders that were weaned at 
booster vaccination had the lowest HWT (P<0.05) (Figure 4).  This dynamic effect on 
HWT within the high responder group of animals based on the timing of wean stress is an 
interesting result which will warrant further investigation. 
Response to vaccination traits effects on carcass quality traits 
The only carcass quality traits showing a significant (P<0.05) interaction between 
final antibody level and wean stress were WBSF and pH (Table 2), indicating a 
difference in relationship between final antibody level and these traits dependent on when 
the wean stress occurred.  Meat pH and WBSF were affected (P < 0.05) by an interaction 
between final antibody level and wean stress (Table 2). For every one-unit increase in 
final antibody level, the pH of meat from booster-weaned animals decreased by 0.016 
(±0.0092) units/animals compared to a 0.012 (±0.0068) unit increase in meat pH for-
every one-unit increase in final antibody level in animals weaned at the initial 
vaccination.  In comparison, WBSF increased 0.029 kg2 (±0.028 kg2) for every one-unit 
increase in final antibody titer level in animals that were weaned at booster vaccination 
compared to a decrease of 0.047 kg2 (±0.022 kg2) for every one unit increase in final 
antibody level in animals weaned at initial vaccination.  Therefore, the meat from animals 
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that were weaned at the initial vaccination and had higher final titer levels was more 
tender than meat from animals that are weaned at the booster vaccination. 
Overall response also showed a significant (P<0.05) interaction with wean stress 
for pH (Table 3).  Animals that had an increased overall antibody response, and were 
weaned at the time of the time of the booster vaccination, have a lower pH compared to 
meat from animals that were weaned at the initial vaccination.  Although, the estimated 
effects were smaller for overall response effects, booster weaned calves had a 0.0139 
(±0.0055) unit increase in pH for every one-point increase in antibody response, as 
compared to a 0.0018 (±0.0043) unit increase in pH per unit of overall response for initial 
wean stress calves. 
However, the interaction between response level and wean stress only had a 
significant (P<0.05) effect on HCW (Table 4).  While animals that had a high antibody 
response level and were weaned at the initial vaccination were numerically the heaviest 
HCW (Figure 5), they were only significantly different from the high responders which 
were weaned at booster.  Similarly, the wean at booster low responder calves were also 
significantly (P<0.05) heavier than the high responder cattle which were weaned at 
booster vaccination.  In comparison, Step et al. (2008) observed no differences in HCW 
between weaned cattle versus weaned and vaccinated, or non-backgrounded (no wean or 
vaccination history) cattle. 
Maes et al. (1998) showed no significant differences (P=0.4116) in carcass traits 
between vaccinated and unvaccinated pigs.  Our results were similar, with no significant 
effects (P<0.05) from antibody levels on carcass quality, thus supporting the notion that 
increased antibody levels do not have deleterious consequences on carcass quality. 
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Wean stress effects on yearling ultrasound measures 
Because no vaccination response variable (final antibody level, overall response, 
and response level) was significant (P>0.05) for UPFAT wean stress treatment had a 
consistent, significant (P=0.01) effect on UPFAT across analyses (Tables 2, 3, and 4). 
Calves that were weaned at booster vaccination had more UPFAT than calves weaned at 
initial vaccination (4.42% ± 0.22% vs 4.24% ± 0.22%, respectively). Additionally, 
UPFAT was significantly (P<0.05) affected by calf age nested within sex and dam age. 
Wean stress effects on performance traits 
Wean stress timing significantly (P<0.01) effects HWT in both the final antibody 
level and overall response models.  Animals that were stressed at the time of the initial 
vaccination were 13.8 kg (± 0.04 kg) heavier at harvest compared to animals that were 
weaned at the booster vaccination for both final antibody level and overall response 
(Figure 6). Stressors, such as weaning, have been shown to have deleterious effects on 
animal performance (Blecha et al., 1984; Salak-Johnson, 2007).  Although, it is 
impossible to avoid stress when weaning calves, improved performance may be observed 
when weaning and initial vaccination occur simultaneously compared to weaning and 
booster vaccination occur at the same time.  Step et al. (2008) showed that calves that 
were weaned prior to feedlot arrival had greater ADG, although no differences were 
shown between calves that were weaned for 45 d versus calves that were weaned for 45 d 
and vaccinated with a modified live vaccine.  Additionally, Step et al. (2008) showed that 
when calves were weaned and vaccinated they had increased BW in the feedlot compared 
to calves that were only weaned.  Even though the results of this study cannot compare 
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unvaccinated calves, increased performance was observed in those calves that were 
weaned at the initial vaccination compared to those weaned at booster vaccination. 
Wean stress effects on carcass quality traits 
While wean stress effects were present in UPFAT at yearling time, at harvest 
wean stress was no longer significant for MARB (P>0.05; Tables 2, 3, and 4). Step et al. 
(2008) observed an increase in YG in calves that were weaned prior to feedlot lot entry or 
weaned and vaccinated.  In contrast, this study did not identify a significant (P>0.05) 
effect of wean stress treatment on YG (Table 2, 3, and 4). 
Research has indicated that increased immune response may have negative affects 
on animal performance.  A number of cytokines have been identified as key regulators in 
immune response are also highly involved in metabolism pathways (Spurlock, 1997).  
However, our data indicates that neither the final antibody level nor the production of 
antibody in response to a vaccination consistently negatively impacted animal 
performance. If increased antibody response was assumed to be a sign of effective 
protection, animals with higher response levels of antibodies were not consistently 
jeopardizing performance to maintain that protection (Figure 3 and Figure 4).  
Vaccination and preconditioning management practices have been found to be successful 
disease prevention methods and strategies to improve herd health (Duff and Galyean, 
2007). 
Conclusion 
Final antibody level or overall response did not have a negative effect on 
performance or carcass quality traits.  Calves weaned at the initial vaccination showed an 
advantage in performance, HCW, and tenderness as compared to those animals that were 
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weaned at the booster vaccination. Animals that had a high antibody response and were 
weaned at the initial vaccination were generally the higher performing animals.  
Therefore, striving for an increased antibody level, which should provide protection 
against BRD, does not appear to cause the previously postulated reduced performance or 
decreased carcass quality.  If acquired antibodies from vaccination can prevent BRD 
outbreaks, and increased antibody levels do not negatively affect ultrasound, 
performance, or carcass quality traits, then BRD prevention through increased antibody 
levels may minimize economic losses associated with reduced performance and 
decreased carcass value from BRD. 
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Table 1.  Means with standard deviation and animal counts are listed for all yearling 
ultrasound, growth performance, and carcass composition traits.  Means are presented by 
sex at yearling data collection time. 
Traits Bulls Steers Heifers 
Yearling Ultrasound n Mean (S.D.) n Mean (S.D.) n Mean (S.D.) 
    YAge (d)1 302 372.0 (20.4) 212 378.1 (20.8) 443 399.8 (16.7) 
    YWT (kg) 1 302 461.8 (52.9) 212 439.0 (51.1) 443 321.1 (46.8) 
    URFAT (cm) 1 301 0.71 (0.20) 212 0.89 (0.23) 443 0.53 (0.20) 
    UFAT (cm) 1 302 0.69 (0.23) 212 0.91(0.23) 443 0.46 (0.18) 
    UREA (cm2) 1 302 74.8 (10.0) 212 71.6 (7.9) 443 50.7 (7.8) 
    UPFAT (%)1 302 4.5 (0.94) 212 5.5 (1.1) 443 4.9 (1.2) 
Performance       
    HAge (d) 1 292 434.6 (38.4) 215 445.1 (23.3) 254 578.3 (46.2) 
    HWT (kg) 1 292 551.1(46.4) 215 513.9 (58.0) 254 521.6 (56.1) 
    ADG (kg/d) 1 292 1.41 (0.17) 215 1.22 (0.15) 254 0.86 (0.13) 
Carcass       
    HCW (kg)  257 337.6 (33.7) 209 316.0 (36.0) 207 315.5 (38.9) 
    CFAT (cm) 1 257 1.0 (0.25) 209 1.1 (0.28) 207 1.3 (0.33) 
    CREA(cm2) 1 257 83.1 (7.0) 209 76.9  (6.0) 207 78.8  (7.5) 
    CKPH, (%)1 257 1.9 (0.50) 209 2.2 (0.46) 207 2.3 (0.51) 
    MARB1 257 5.62 (0.98) 209 6.54 (1.04) 207 6.87 (1.08) 
    YG1 257 2.58 (0.50) 209 2.89 (0.46) 207 2.96 (0.52) 
    WBSF (kg) 1 228 3.608 (0.976) 177 3.340 (0.831) 187 3.396 (1.088) 
    pH 255 5.71 (0.33) 206 5.50 (0.08) 206 5.48 (0.15) 
 
1YAge = calf age at yearling ultrasound data collection; WT = yearling live weight at 
ultrasound collection; URFAT = subcutaneous fat thickness over the termination point of 
the biceps femoris in the rump; UFAT = subcutaneous fat thickness at $ the lateral 
distance across the LM between the 12th and 13th ribs; UREA = LM area between 12th 
and 13th ribs; UPFAT = percent i.m. fat within the LM between the 12th and 13th ribs; 
HAge = age at collection of harvest live WT; HWT = live harvest weight one to seven 
days prior to harvest; ADG = ADG between weaning and harvest (HWY-weaning WT/ 
harvest age-weaning age); CFAT = subcutaneous fat thickness at $ the lateral distance 
across the LM between the 12th and 13th ribs; CREA = LM area using plastic dot grid 
overlay between the 12th and 13th ribs; CKPH = estimated percent kidney, pelvic, and 
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heart fat; MARB = MARB to the nearest 10 marbling score units, (3.00 = Traces00; 4.00 
= Slight00; 5.00 = Small00; 6.00 = Modest00; 7.00 = Moderate00; 8.00 = Slightly 
Abundant00; and 9.00 = Moderately Abundant00); YG = yield grade calculated: YG = 
2.5 + (0.984 % CFAT, cm) + (0.2 % CKPH, %) + (0.0084 % HCW, kg) - (0.05 % CREA, 
cm2); WBSF = Warner-Bratzler shear force. 
!!
"+*!
Table 2 Model R2 and P-values for fixed sources of variation for yearling ultrasound, 
growth performance, and carcass composition traits with final titer effect and wean stress 
timing. 
  Final Antibody Level Model Effect1 
 R2 R WS R*WS CG DA PE Doc A(Sex) 
Yearling Ultrasound          
    YWT (kg) 2 0.83 0.02 … … <0.01 <0.01 0.03 … <0.013 
    URFAT(cm)2 0.54 <0.01 … … <0.01 <0.01 0.01 … <0.013 
    UFAT(cm)2 0.62 … … … <0.01 <0.01 … … <0.013 
    UREA(cm2)2 0.80 … … … <0.01 … 0.01 … <0.013 
    UPFAT(%)2 0.25 … 0.01 … <0.01 … … … <0.013 
Performance          
    HWT (kg) 2 0.45 … <0.01 … <0.01 … … <0.01 <0.014 
    ADG (kg/day) 2 0.82 … … … <0.01 … 0.02 <0.01 … 
Carcass          
    HCW(kg) 0.42 … … … <0.01 <0.01 … … <0.015 
    CFAT(cm)2 0.33 … … … <0.01 0.05 … … <0.015 
    CREA(cm2)2 0.29 … … … <0.01 … … … <0.015 
    CKPH(%)2 0.24 … … … <0.01 … … … 0.035 
    MARB2 0.42 … … … <0.01 … … … <0.015 
    YG2 0.32 … … … <0.01 … … … <0.015 
    WBSF(kg)2 0.51   0.026 <0.01 … … … … 
    pH 0.40   <0.016 <0.01 <0.01 … … … 
…  Non-significant effects in the model 
1 R2 =variance accounted for the model with significant effects as listed. R = immune 
response measured through final antibody level; WS = wean stress timing (initial (I) or 
booster (B); R*WS = interaction term of final titer by wean stress (final titer when WS=I 
or final titer when WS=B); CG = post weaning management group (year, season, sex, and 
scan group) (n=21 CG groups); DA = dam age (years, two to eleven years old); PE = 
pinkeye (yes/no); Doc = docility score (six point scale; yearling docility used for yearling 
traits, pre-harvest docility score used for performance and carcass traits); and A(Sex) = 
age (yearling or pre-harvest, depending on traits; in days) nested within yearling sex 
(Sex=bulls, steers, or heifers).  WS, CG, DA, PE, and Doc were fit as class effects. 
2 YWT = yearling live weight at ultrasound collection; URFAT = subcutaneous fat 
thickness over the termination point of the biceps femoris in the rump; UFAT = 
!!
""+!
subcutaneous fat thickness at $ the lateral distance across the LM between the 12th and 
13th ribs; UREA = LM area between 12th and 13th ribs; UPFAT = percent i.m. fat within 
the LM between the 12th and 13th ribs; HWT = live harvest weight within 7 days prior to 
harvest; ADG = ADG between weaning and harvest (HWY-weaning WT/ harvest age-
weaning age); CFAT = subcutaneous fat thickness at $ the lateral distance across the LM 
between the 12th and 13th ribs; CREA = LM area using plastic dot grid overlay between 
the 12th and 13th ribs; CKPH = estimated percent kidney, pelvic, and heart fat; MARB = 
MARB to the nearest 10 marbling score units, (3.00 = Traces00; 4.00 = Slight00; 5.00 = 
Small00; 6.00 = Modest00; 7.00 = Moderate00; 8.00 = Slightly Abundant00; and 9.00 = 
Moderately Abundant00); YG = yield grade calculated: YG = 2.5 + (0.984 % CFAT, cm) 
+ (0.2 % CKPH, %) + (0.0084 % HCW, kg) - (0.05 % CREA, cm2); WBSF = Warner-
Bratzler shear force. 
3 YAge = calf age at yearling ultrasound data collection 
4 PreAge = age at collection of HWT (collection of performance data) 
5  HAge = age at harvest 
6 When R*WS was significant (P<0.05); P-values for R and WS were not listed. 
 
!!
"""!
Table 3. Model R2 and P-values for fixed sources of variation for yearling ultrasound, 
growth performance, and carcass composition traits with overall response effect and 
wean stress timing. 
  Overall Antibody Response Model Effect1 
 R2 R WS R*WS CG DA PE Doc A(Sex) 
Yearling Ultrasound          
    YWT (kg) 2 0.82 … … … <0.01 <0.01 0.02 … <0.013 
    URFAT(cm)2 0.54 … … … <0.01 <0.01 <0.01 … <0.013 
    UFAT(cm)2 0.62 … … … <0.01 <0.01 … … <0.013 
    UREA(cm2)2 0.80 … … … <0.01 … 0.01 … <0.013 
    UPFAT(%)2 0.25 … 0.01 … <0.01 … … … <0.013 
Performance          
    HWT (kg) 2 0.45 … <0.01 … <0.01 … … <0.01 <0.014 
    ADG (kg/day) 2 0.82   0.046 <0.01 … 0.01 <0.01 … 
Carcass          
    HCW(kg) 0.42 … … … <0.01 <0.01 … … <0.015 
    CFAT(cm)2 0.33 … … … <0.01 0.05 … … <0.015 
    CREA(cm2)2 0.29 … … … <0.01 … … … <0.015 
    CKPH(%)2 0.25 … … … <0.01 … … … 0.035 
    MARB2 0.42 … … … <0.01 … … … <0.015 
    YG2 0.32 … … … <0.01 … … … <0.015 
    WBSF(kg)2 0.50 … … … <0.01 … … … … 
    pH 0.40   0.036 <0.01 0.03 … … … 
…  Non-significant effects in the model 
1 R = immune response measured as overall response (final titer – initial titer); WS = 
wean stress timing (initial (I) or booster (B)); R*WS = interaction term of overall 
response by wean stress (overall response when WS=I or overall response when WS=B); 
CG = post weaning management group (year, season, sex, and scan group) (n=21 CG 
groups); DA = dam age (years, two to eleven years old); PE = pinkeye (yes/no); Doc = 
docility score (six point scale; yearling docility used for yearling traits, pre-harvest 
docility score used for performance and carcass traits); and A(Sex) = age (yearling or pre-
harvest, depending on traits; in days) nested within yearling sex (Sex=bulls, steers, or 
heifers).  WS, CG, DA, PE, and Doc were fit as class effects. 
2 YWT = yearling live weight at ultrasound collection; URFAT = subcutaneous fat 
thickness over the termination point of the biceps femoris in the rump; UFAT = 
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subcutaneous fat thickness at $ the lateral distance across the LM between the 12th and 
13th ribs; UREA = LM area between 12th and 13th ribs; UPFAT = percent i.m. fat within 
the LM between the 12th and 13th ribs; HWT = live harvest weight one to seven days 
prior to harvest; ADG = ADG between weaning and harvest (HWY-weaning WT/ harvest 
age-weaning age); CFAT = subcutaneous fat thickness at $ the lateral distance across the 
LM between the 12th and 13th ribs; CREA = LM area using plastic dot grid overlay 
between the 12th and 13th ribs; CKPH = estimated percent kidney, pelvic, and heart fat; 
MARB = MARB to the nearest 10 marbling score units, (3.00 = Traces00; 4.00 = 
Slight00; 5.00 = Small00; 6.00 = Modest00; 7.00 = Moderate00; 8.00 = Slightly 
Abundant00; and 9.00 = Moderately Abundant00); YG = yield grade calculated: YG = 
2.5 + (0.984 % CFAT, cm) + (0.2 % CKPH, %) + (0.0084 % HCW, kg) - (0.05 % CREA, 
cm2); WBSF = Warner-Bratzler shear force. 
3 YAge = calf age at yearling ultrasound data collection 
4 PreAge = age at collection of HWT (collection of performance data) 
5  HAge = age at harvest 
6 When R*WS was significant (P<0.05); P-values for R and WS were not listed. 
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Table 4. Model R2 and P-values for fixed sources of variation for yearling ultrasound, 
growth performance, and carcass composition traits with response level (non-, low, or 
high) effect and wean stress timing. 
  Response Level Model Effect1 
 R2 R WS R*WS CG DA PE Doc A(Sex) 
Yearling Ultrasound          
    YWT (kg) 2 0.82 … … … <0.01 <0.01 0.02 … <0.013 
    URFAT(cm)2 0.54 0.02 … … <0.01 <0.01 <0.01 … <0.013 
    UFAT(cm)2 0.62 … … … <0.01 <0.01 … … <0.013 
    UREA(cm2)2 0.80 … … … <0.01 … 0.01 … <0.013 
    UPFAT(%)2 0.25 … 0.01 … <0.01 … … … <0.013 
Performance          
    HWT (kg) 2 0.46   0.036 <0.01 … … <0.01 <0.014 
    ADG (kg/day) 2 0.82   <0.016 <0.01 … 0.02 <0.01 … 
Carcass          
    HCW(kg) 0.43   0.036 <0.01 <0.01 … … <0.015 
    CFAT(cm)2 0.33 … … … <0.01 0.05 … … <0.015 
    CREA(cm2)2 0.29 … … … <0.01 … … … <0.015 
    CKPH(%)2 0.24 … … … <0.01 … … … 0.035 
    MARB2 0.42 … … … <0.01 … … … <0.015 
    YG2 0.32 … … … <0.01 … … … <0.015 
    WBSF(kg)2 0.50 … … … <0.01 … … … … 
    pH 0.39 … … … <0.01 0.04 … … … 
…  Non-significant effects in the model 
1 R = immune response measured through response levels (non-, low, and high 
responders); WS = wean stress timing (initial (I) or booster (B)); R*WS = interaction 
term of response level by wean stress (response level when WS=I or response level when 
WS=B); CG = post weaning management group (year, season, sex, and scan group) 
(n=21 CG groups); DA = dam age (years, two to eleven years old); PE = pinkeye 
(yes/no); Doc = docility score (six point scale; yearling docility used for yearling traits, 
pre-harvest docility score used for performance and carcass traits); and A(Sex) = age 
(yearling or pre-harvest, depending on traits; in days) nested within yearling sex 
(Sex=bulls, steers, or heifers).  R, WS, R*WS, CG, DA, PE, and Doc were fit as class 
effects. 
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2 YWT = yearling live weight at ultrasound collection; URFAT = subcutaneous fat 
thickness over the termination point of the biceps femoris in the rump; UFAT = 
subcutaneous fat thickness at $ the lateral distance across the LM between the 12th and 
13th ribs; UREA = LM area between 12th and 13th ribs; UPFAT = percent i.m. fat within 
the LM between the 12th and 13th ribs; HWT = live harvest weight one to seven days 
prior to harvest; ADG = ADG between weaning and harvest (HWY-weaning WT/ harvest 
age-weaning age); CFAT = subcutaneous fat thickness at $ the lateral distance across the 
LM between the 12th and 13th ribs; CREA = LM area using plastic dot grid overlay 
between the 12th and 13th ribs; CKPH = estimated percent kidney, pelvic, and heart fat; 
MARB = MARB to the nearest 10 marbling score units, (3.00 = Traces00; 4.00 = 
Slight00; 5.00 = Small00; 6.00 = Modest00; 7.00 = Moderate00; 8.00 = Slightly 
Abundant00; and 9.00 = Moderately Abundant00); YG = yield grade calculated: YG = 
2.5 + (0.984 % CFAT, cm) + (0.2 % CKPH, %) + (0.0084 % HCW, kg) - (0.05 % CREA, 
cm2); WBSF = Warner-Bratzler shear force. 
3 YAge = calf age at yearling ultrasound data collection 
4 PreAge = age at collection of HWT (collection of performance data) 
5  HAge = age at harvest 
6 When R*WS was significant (P<0.05); P-values for R and WS were not listed. 
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Figure 1. Diagram of serum sample collection (blood tube icon), vaccination timing 
(syringe icon), and weaning timing (large open arrow). The syringes at week 0 and 3 
indicate time when vaccine was administered to calves. The collection tubes indicate the 
three serum collection time points. a) Antibody level at initiation of the vaccination 
protocol (n=1,004). b) Antibody level in calves 3 weeks after the initial vaccination, i.e. 
response to initial vaccination and at time of booster vaccination. c) Final antibody level 
achieved following the 2-shot protocol.  The first arrow indicates that half (n=508) of the 
calves were weaned at initial vaccination.  The second arrow indicates the time of 
weaning for the second half (n=496) of the calves. 
!
!!
""'!
 !
!!!!
 
 
Figure 2. Least square means of URFAT (cm) based on response level group.  Least 
square mean with different letters are statistically different (P<0.05). 
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Figure 3.  Effects of response level (non, low, high) by wean stress (initial or booster) on 
ADG (kg/day) in harvested animals.  Least square mean with different letters are 
significantly different (P<0.05). 
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Figure 4.  Effects of response level (non, low, high) by wean stress (initial or booster) on 
HWT (kg) at time of harvest.  Least square mean with different letters are significantly 
different (P<0.05). 
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Figure 5.  Effects of response level (non, low, high) by wean stress (initial or booster) on 
HCW (kg) in harvested animals. Least square mean with different letters are statistically 
different (P<0.05). 
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Figure 5.  LSMeans for wean stress treatment effects on HWT (kg) for both final 
antibody level and overall response analysis models.  Least square mean with different 
letters are statistically different (P<0.05). 
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CHAPTER 7.!
GENERAL CONCLUSIONS!
There are numerous challenges associated with genetic improvement for disease 
resistance.  Herd health is a primary concern facing beef operation management today.  
Due to the major impact that bovine respiratory disease (BRD) has had on the beef 
industry, genetic resistance has shown to offer minimal improvement over long 
generation intervals.  Therefore, preventative methods, such as vaccination against 
infectious pathogens, have become a focal point for improved disease prevention.  This 
study investigated bovine viral diarrhea virus type 2 (BVDV2) antibody response to 
BVDV2 vaccinations, as a potential preventative practice against BRD. 
 This study identified that maternal antibodies were not transferred equally to 
calves and maternal BVDV2 antibodies decay at different rates depending (P<0.05) on 
the age of the dam and the amount of passive antibodies.  Younger cows transfer fewer 
antibodies than older cows, there were significant (P<0.05) differences seen in the 
quantity of antibodies that were transferred by two to five year old dams.  While maternal 
antibodies are a vital component to early immunity in calves, maternal antibodies have 
been shown to block acquired antibody response to vaccination.  Maternal antibodies 
were found to have a significant (P<0.05) affect on final antibody level and initial, 
booster, and overall antibody responses to BVDV2 vaccinations. Calves that had 
maternal antibody levels lower than 3.12 titer units at vaccination had increased overall 
response to vaccination.  This indicates that antibody response to vaccination increased as 
the presence of maternal antibodies decreased.  Additionally, older calves had greater 
antibody responses to vaccination than younger calves.  This may have been due to the 
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relationship of calf age and maternal antibody levels, as calf age increased maternal 
antibodies decreased.  When weaning stress and vaccination occur simultaneously, calves 
that were weaned at the initial vaccination had an increased response to the initial 
vaccination and overall response.  This indicates that to optimize response to vaccination 
when management practices occur simultaneously, weaning at the initial vaccination will 
allow an increased antibody response.   
 Performance and carcass quality traits do not appear to be jeopardized with 
increased final antibody level or overall antibody response.  Calves that were weaned at 
the initial vaccination showed increased performance in ADG, HWT, HCW and meat 
tenderness. Calves that were weaned at the initial vaccination and were classified as high 
antibody responders had increased performance compared to other calves weaned at 
initial vaccination or weaned at the boost vaccination.  
 This data indicates that when weaning stress and vaccination occur 
simultaneously, weaning calves at the initial vaccination offers an opportunity for 
increased antibody response to BVDV2 vaccination.  Additionally, those calves that were 
weaned at the initial vaccination also saw improved performance in the feedlot.  
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APPENDIX 
ENVIRONMENTAL AND MANAGEMENT FACTORS INFLUENCING BVDV2 
ANTIBODY LEVELS AND RESPONSE TO VACCINATION IN WEANLING 
CALVES 
Published in the 2011 BIF Conference Proceedings 
E.D. Downey1, J.F. Ridpath2, R.G. Tait1, Jr., D.J. Garrick1, J.M. Reecy1 
1 Iowa State University, Ames, IA 
2 National Animal Disease Center USDA-ARS, Ames, IA 
Summary 
Vaccination has many benefits for disease prevention and overall health status of 
animals.  Not all animals respond equally to vaccinations.  A number of factors can be 
shown to influence a young animal’s response to vaccination.  Calves with more maternal 
antibodies at the time of vaccination have poorer immune response.  The level of 
maternal antibodies at the time of vaccination is influenced by the amount of passive 
immunity transfer obtained via colostrum in the first 24 hours and the subsequent loss of 
maternal antibodies over the period up until vaccination.  Younger dams appear to supply 
fewer passive antibodies to their calves and these maternal antibodies from younger dams 
appear to degrade at a faster rate than those from older dams. The level of response 
achieved in vaccinated calves varies by calving season.  Vaccination during periods of 
high stress, such as weaning, has shown negative impacts on response. Further, calf age 
impacted the ability of a calf to mount an antibody response.   In the Iowa State herd, 
calves averaged 130 days of age to elicit a positive response to vaccination.  Collectively, 
these data suggest ranchers may be able to improve the value of vaccination by avoiding 
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this activity at weaning and by consideration of the age of the dams, and the age of the 
calves at vaccination.  
Introduction 
Bovine Respiratory Disease 
Bovine respiratory disease (BRD) has the greatest incidence among feedlot 
diseases and has the largest negative economic impact, with an estimated cost of $750 
million annually, to the feedlot industry (Holland et al., 2010).  It has been characterized 
as a complex disease that involves environment, stress, and infectious pathogens (Step et 
al., 2009).  The viral agents most often associated with BRD are bovine viral diarrhea 
virus (BVDV), bovine respiratory syncytial virus (BRSV), bovine infectious 
rhinotrachetious (BIR), and parainfluenza 3 (PI3) (Salt et al., 2007).  BRD is seldom 
caused solely by a viral pathogen, but most often is the result of a secondary bacterial 
infection, which resulted due to a weakened immune system as a consequence of the viral 
pathogen infection (Salt et al., 2007).    
Vaccination 
Vaccination is currently used as a primary method for prevention of respiratory 
disease. Vaccination has been shown to improve animal health and productivity by 
reducing disease incidence as animals move through production phases. Optimization of 
vaccination protocols to decrease disease prevalence provides an opportunity to reduce 
these losses.  It has been shown that vaccination of weaned cattle prior to arrival into the 
feedlot can prevent infectious diseases that may lead to the onset of BRD (Kirkpatrick et 
al., 2008).   While the practice of vaccination has been adopted in many production 
systems, a protective response from the vaccines is still necessary for disease prevention. 
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Maternal Antibodies 
Newborn calves passively acquire antibodies from their dams via consumption of 
colostrum immediately after birth.  However, factors such as dam age, quality and 
quantity of colostrum, and timeliness of colostrum consumption may influence the 
amount of maternally derived antibodies present in the circulatory system of a calf.  As a 
calf’s immune system is not fully developed at birth, maternal antibodies are important 
for prevention of disease, such as infection of BVDV shortly after birth.  However, 
passively acquired antibodies have been shown to block the ability of the calves’ immune 
system to mount an antibody response to vaccination, and therefore may need to have 
decreased to a sufficiently low level in order for calves to respond to vaccines 
(Menanteau-Horta et al., 1985).   There is a period of vulnerability, during the period that 
maternal antibodies have regressed up until the time vaccination has induced a sufficient 
level of protection.  This vulnerability period impacts a manager’s decision about when to 
vaccinate calves to elicit a protective response (Endsley et al., 2003).  Therefore, the age 
of dam, total passive immunity transferred, and the maternal antibody decline rate may be 
important factors to consider when developing a vaccination protocol. 
Stress 
There have been a number of studies that have shown that stress has deleterious 
effects on antibody development, growth performance, and carcass quality in calves 
(Niekamp et al., 2007; Richeson et al., 2008; Salak-Johnson, 2007; Step et al., 2008).  
Some high stress periods have been identified as weaning, transportation, de-horning, 
castration, bunk breaking, and commingling (Elenkov, 2002).  Weaning has often been 
incorporated with vaccination to reduce labor needs.  However, this may have detrimental 
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effects on an animal’s ability to respond to vaccinations.  Therefore, minimizing stress at 
the time of vaccination may likely give the best return on vaccine use.  However, this 
may not always be a viable management option.   
Vaccination of cattle has been considered a standard management procedure for 
disease prevention, and remains one of the most effective methods for disease prevention.  
There are environmental and genetic factors that contribute to an animal’s ability to 
respond; both are of interest for improved immune response (O'Neill et al., 2006; 
Richeson et al., 2008).  There are management factors that can be controlled by producers 
such as, but not limited to, induced stress, calf age at vaccination, and animal nutrition, 
which can enhance or impede the vaccine response of calves (Bagley, 2001).  While 
vaccination is a disease prevention method, animals must develop a protective response 
from the vaccine in order to actively protect against pathogens.  The goal of this project 
was to develop vaccination management recommendations, which increase the 
effectiveness of vaccinations.  In this study, weanling calves were evaluated to identify 
factors that effect maternal antibody transfer and persistence in the calf along with 
environmental factors that impact an animal’s ability to respond to vaccination.   
Materials and Methods 
Sample Collection 
To evaluate response to BVDV type II vaccination, data and serum samples were 
collected from 1,012 purebred American Angus calves from the Iowa State University 
breeding project at the ISU McNay Research and Demonstration farm.  Calves were born 
in 2007, 2008, and 2009 with 334, 354, and 324 calves born in each year, respectively. 
The cow herd was managed in two calving seasons with 380 calves born in the fall 
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season and 632 calves in the spring season.  Animals were vaccinated using a standard 
two-shot protocol, with shots administered approximately three weeks apart, as suggested 
by the vaccine manufacturer.  All calves in this study were vaccinated with the 
recommended 2cc dose of Pfizer Bovisheild Gold-5®.  In addition to response to BVDV 
II vaccination evaluation, the effect of wean stress on the ability of calves to respond to 
vaccination was incorporated.  Approximately half of the calves in each year/season were 
weaned at initial vaccination and the other half of the calves were weaned at booster 
vaccination, with 512 and 500 animals being weaned in each group, respectively (Figure 
1).  To evaluate antibody levels and response measurements, serum samples were 
collected at four time points. The first sample was collected three weeks prior to the 
initial vaccination (pre-vaccination) to quantify the level of maternal antibodies present 
in the calves and enable assessment of maternal antibody loss over a period of time prior 
to vaccination.  Three other samples were collected: just prior to the initial vaccination 
(initial); at booster vaccination (booster); and three weeks post booster vaccination 
(final) (Figure 1).  Serum was analyzed using a viral neutralization assay to quantify 
BVDV II neutralizing antibodies.  These neutralizing antibodies were the BVDV II 
specific antibodies that were present in the serum that were capable of attaching to the 
virus and preventing infection, this was done using a serial dilution of individual calf’s 
serum.  The highest dilution of serum that carried enough antibodies to protect against the 
virus was reported as a titer score. The higher the titer score the higher the level of 
antibodies present in the serum of a calf, which should equate to an increased protection 
against viral infection. 
Variable Calculations 
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Pre-vaccination and initial titer levels were used to evaluate maternal antibody 
transfer and rate of maternal antibody regression.  Initial titer was used with pre-
vaccination titer to determine the rate of maternal antibody decline (Figure 2).  
Maternal antibody decline was calculated as the difference between initial and pre-
vaccination titers divided by the number of days between the two samples. 
Final titer was used to evaluate total antibody development of the animal three weeks 
post booster vaccination (end of the vaccination protocol).   Three response variables 
were also evaluated: response to initial vaccination, response to booster vaccination, 
and overall response. Response to initial vaccination was calculated as the difference 
between the booster and initial titers.  Response to booster vaccination was calculated as 
the difference between final and booster titers.  Overall response was calculated as the 
difference between initial and final titers (Figure 2). 
Results 
Environmental Factors 
Effects of: dam age, calf age, circulation of maternal antibodies, year by season, 
time of wean stress, and gender were evaluated for their influence on antibody levels and 
response to vaccination variables.  Calf gender was not found to influence antibody levels 
or affect overall response to vaccination.  However, there was a significant difference 
seen in year by season groups. 
Means and Correlations 
Pre-vaccination and initial serum antibody levels were evaluated for age of dam 
effects, specifically for differences in maternal antibody transfer.  Additionally, rate of 
decline of maternal antibody decline was evaluated on dams of different ages.  Table 1 
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has the observed means with standard deviations for titer score (base 2 log), calf age 
(days), and weight (lbs) for the four collection time points (pre-vaccination, initial, 
booster, and final).  These means are then broken down by season, as seasonal 
differences have been observed. 
Calf age (days), age of dam (years), and weight (lbs) were correlated with pre-
vaccination, initial and final antibody levels to evaluate their relationships.  Calf age had 
a higher correlation with pre-vaccination and initial antibody level than did calf weight 
(Table 2).  Thus, calf age may be the more informative indicator of maternal antibody 
levels in the calf’s circulatory system.  Additionally, age of dam was also highly 
correlated with both pre-vaccination and initial antibody levels. Therefore, there may be 
differences in maternal contributions depending on the age of the dam. 
Maternal Antibody Acquisition and Decline 
Pre-vaccination and initial antibody levels were representative of the amount of 
passive antibodies that were acquired by calves.  It is expected that this passively 
acquired immunity will erode over time.  By including calf age as a covariate for pre-
vaccination or initial titers, a generalized rate of maternal antibody decline was estimated 
and the level of maternal antibody transferred at birth was then estimated.  The general 
maternal antibody decline can be seen in Figure 3, as there is a decline between pre-
vaccination and initial antibody levels. 
Pre-vaccination and initial antibody levels, after correction for calf age, were 
significantly influenced by dam age (Figure 3).   There was a significant difference in the 
transfer of passive immunity for each dam age group for two to five year old dams, but 
once cows reach five years of age there were no further differences in the amount of 
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maternal antibodies transferred to the calf (see Figure 3).  The improvement in passive 
antibody transfer seen across dam age could be due to differences in colostrum quality 
and quantity that was available to calves and timeliness of colostrum intake by calves (i.e. 
how quickly the dam mothered up the calf to nurse).   
Differences in animal specific maternal antibody decline rate were evaluated by 
age of dams in this population.  The rate of maternal antibody decline in calves from 
younger cows was faster than the rate of decline observed in calves from older dams 
when year by season, age of dam, calf age, and pre-vaccination titers were accounted for 
(Table 3).  Recognizing that two-year old dams have transferred fewer maternal 
antibodies to their offspring, their calves would potentially reach negligible levels of 
maternal antibody at a younger age and therefore be vulnerable to a natural infection at a 
younger age than calves from older dams.  Thus, calves from younger dams may need to 
be vaccinated at a younger age to provide them with adequate protection against viral 
infection. 
Maternal Antibody Interference 
Maternal antibodies serve protective roles in young calves with immature immune 
systems, but high levels of maternal antibodies at the time of vaccination can impede the 
development of the specific immune system in calves.  Figure 4 displays mean antibody 
level (titers) by age of dam across the four collection time points (pre-vaccination, initial, 
booster, and final antibody levels).  Calves from younger dams had lower maternal 
antibody levels at pre-vaccination.  High maternal antibody levels can block/inhibit the 
immune systems ability to respond to vaccination.  Maternal antibodies present at the 
time of vaccination were shown to inhibit overall response to vaccination by -1.2 titer 
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scores for every 1-point titer increase in circulating maternal antibodies at initial 
vaccination.  Therefore, at day 0, when calves were administered the initial vaccine, those 
calves that were from younger dams had lower initial titer scores and were more likely to 
develop and antibody response to vaccination.  Thus, enabling those calves to show a 
greater overall response to vaccination. 
Calf Age 
Beyond age of dam, calf age also significantly affected pre-vaccination and initial 
antibody levels.  To look at the age affects on antibody level over time, calves were 
grouped by age in 21-day intervals (Figure 5).  Not surprisingly, younger calves tended 
to have higher initial antibody levels compared to older calves, while older calves had a 
higher antibody level at the final response and had a greater overall response to 
vaccination (see Figure 5).  The ability of older calves to mount a high overall response 
may be explained by the removal of more maternal antibodies that could inhibit a 
response to vaccines.  These results indicate that vaccinating calves at an older age will 
allow them to mount a larger positive response to vaccination.    
As another method to evaluate the effect of calf age on time vaccination, calves 
were separated into non-responders, low responders, and high responders.  Non-
responder calves had a negative or zero overall response, with titers less than zero.  Low 
responder calves had overall response titers from zero to five.  While, high responders 
were calves that had overall response titers (antibody levels) of five or more.  Forty-nine 
percent of the calves were classified as non-responders, 28% were classified as at low 
responders, and 23% were classified as high responders.  The LSMeans for age at initial 
vaccination for these response groups were then estimated (Table 4).   There were 
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significant differences by response group in their ages at vaccination.  In this study, the 
calves that achieved a positive overall response to the vaccination were on average 130 
days old at the time of the initial vaccination vs. 123 days old for. 
Weaning Stress Interference 
Periods of high stress are known to suppress the immune system and thereby 
increase the risk of disease during these elevated stress periods (Salak-Johnson, 2007).  
Weaning has been identified as a high stress period in cattle that could affect the immune 
response (Niekamp et al., 2007). This immune suppression, caused from weaned calves, 
affects antibody response in vaccinated cattle.  Therefore, vaccination of calves in a stress 
free environment would be the ideal management practice.  However, in many 
commercial operations, this is not a practical management option and weaning and 
vaccination occur  
simultaneously.    Therefore, it has been shown that timing of weaning can have 
significant effects on an animal’s ability to respond (Figure 6; Niekamp et al., 2007).  
This effect of weanstress timing was evaluated for the three response variables.  Two 
weanstress times were identified, weaning at the initial vaccination and weaning at the 
booster vaccination, as these may be typical management practices applied in production 
settings.  Figure 6 illustrates the effects of these two weanstress periods.  Once year and 
season differences are accounted for, animals weaned at the initial vaccination elicited a 
higher overall response than calves weaned at the booster vaccination. Therefore, if a 
high stress activity, such as weaning, was implemented at time of vaccination, there is a 
greater overall response from those calves that experienced the stress at the initial 
vaccination. 
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Conclusion 
Timing of vaccination is very important in order to induce a protective antibody 
response in weanling calves.  Optimal timing of vaccination is influenced by both age of 
dam and calf age.  Increases were seen in the amount of antibody transfer for each dam 
age group from two to five year olds, once cows reached five years of age no significant 
differences in maternal antibody transfer were seen.  The rate of maternal antibody 
decline is also dam age dependent, with younger cows having a faster antibody decline 
rate.  The amount of maternal antibodies transferred and the rate of decline will both 
influence the optimum calf age for vaccination to enable a positive response.  Before a 
vaccination can have a positive response, maternal antibodies must have declined to a 
level low enough not to immediately neutralize antigens from vaccines.  Therefore, 
calves from younger dams would be eligible to be vaccinated at a younger age than 
calves from older cows to avoid periods of infection vulnerability. This age at which to 
vaccinate calves was also influenced by passively acquired immunity.  As maternal 
antibody level needs to decline to a sufficiently low level so that an immune response can 
be elicited response.  However, calves need to be vaccinated before they enter into a 
vulnerable period for infection.   Stress can negatively impact immune response to 
vaccination, however if weaning stress and vaccination occur simultaneously, calves that 
were weaned at the initial vaccination saw an increased overall response. 
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Table 1. Means for titer level, calf age, and calf weight at four serum collection time 
points, which were collected ~21 days apart. Data are also reported by calving season, 
spring or fall. 
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Table 2. Correlations for pre-vaccination, initial, and final antibody (titer) levels with 
calf age, dam age, or calf weight. 
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Table 3.  LSMean for rate of decline of maternal antibodies by age of dam.  Estimates 
with different superscript (a,b,c) are significantly different at P<0.05. 
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Table 4. LSMean for age at vaccination by response to vaccination group: non-
responders, low responders, and high responders.  Superscripts indicate significant 
differences in ages at P<0.05.  Year by season has been accounted for in the age at 
vaccination mean. 
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Figure 1. Diagram of serum sample collection, vaccination timing, and weaning timing. 
The syringes at week 0 and 3 indicate time when vaccine was administered to calves. The 
collection tubes indicate the four serum collection time points. a) Pre-vaccination 
antibody level (n=615). b) Antibody level at initiation of the vaccination protocol 
(n=1,012). c) Antibody level in calves 3 weeks after the initial vaccination (n=1,012), i.e. 
response to initial vaccination and at booster. d) Final antibody level achieved following 
the 2-shot protocol (n=1,012).  The green arrow indicates that half (n=512) of the calves 
were weaned at initial vaccination.  The blue arrow indicates the time of weaning for the 
second half (n=500) of the calves. 
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Figure 2.  Collection tubes represent the times of serum collections and therefore the 
titers at these points.  The arrows indicate the evaluated variables, a) pre-vaccination titer 
level, b) initial titer, c) booster titer, d) final titer, e) decline of maternal antibodies, f) 
response to initial vaccination, g) response to booster vaccination, h) overall response. 
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Figure 3. LSMean titer scores for dam age for pre-vaccination and initial antibody levels.  
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Figure 4.  Average (raw means) antibody level (titer scores) for the four collection time 
points (-21, 0, 21, and 42 days) by dam age (2 through 11 year old dams).  Number of 
calves for each dam age is listed in parentheses following the dam age label, with sample 
number at pre-vaccination followed by the number of calves for the three subsequent 
collection timepoints. 
!
+!"!
#!$!
%!&!
'!(!
)!
G%+! G#+! +! #+! %+! '+!
6
%7
1$
!"
8*
$1
!2
)
,4
1!
=
!-*
'5
!
.,34!91-,7%<1!7*!>&%7%,-!L,88%&,7%*&!
#!L3Z**<!"%(N!$!L3Z"+#<!"&(N!%!L3Z*)<!"%)N!&!L3Z!()<!"'$N!'!L3Z((<!"$*N!(!L3Z)+<!""$N!)!L3Z%+<!'#N!*!L3Z#(<!%*N!"+!L3Z"+<!#"N!""!L3Z&<!"$N!
!!
"%&!
 
 
 
 
 
 
 
 
Figure 5.  LSMean for calves grouped by 21-day intervals by age for maternal, initial, 
booster, and final antibody titer comparison, with the sample number listed by maternal 
titer, initial titer. The older calves show less circulating maternal antibodies at the 
beginning of the vaccination protocol and higher final response to vaccinations. 
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Figure 6.  LSMean titer scores for the two weanstress periods for initial response, booster 
response and overall response.  Animals weaned at initial vaccination elicit a greater 
response to vaccination than animals weaned at booster vaccinations. 
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